Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Vincent Soriano

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Living Beings

Chemicals & Drugs

Geographic Areas

Spain

Concepts & Ideas

Viral Load

Physiology

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Madejón A; Vispo E; Bottecchia M; Sánchez-Carrillo M; García-Samaniego J; Soriano V
Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations.
Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
Rodriguez-Novoa Sonia; Labarga Pablo; Soriano Vincent
Pharmacogenetics of tenofovir treatment.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Vincent Soriano (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Madejón A; Vispo E; Bottecchia M; Sánchez-Carrillo M; García-Samaniego J; Soriano V
Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations.
Journal of viral hepatitis 2009;16(12):895-6.
2009: Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
Journal of viral hepatitis 2009;16(11):790-5.
2009: Rodriguez-Novoa Sonia; Labarga Pablo; Soriano Vincent
Pharmacogenetics of tenofovir treatment.
Pharmacogenomics 2009;10(10):1675-85.
2009: De Mendoza Carmen; Garrido Carolina; Poveda Eva; Corral Angélica; Zahonero Natalia; Treviño Ana; Anta Lourdes; Soriano Vincent
Changes in drug resistance patterns following the introduction of HIV type 1 non-B subtypes in Spain.
AIDS research and human retroviruses 2009;25(10):967-72.
2009: Salgado María; Toro Carlos; Simón Ainhoa; Garrido Carolina; Blanco Francisco; Soriano Vincent; Rodés Berta
Mutation N155H in HIV-2 integrase confers high phenotypic resistance to raltegravir and impairs replication capacity.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2009;46(2):173-5.
2009: Morello Judit; De Mendoza Carmen; Soriano Vincent; Anta Lourdes; González-Pardo Gema; Corral Angélica; Blanco Francisco; Jiménez-Nácher Inmaculada; González-Lahoz Juan; Rodríguez-Novoa Sonia
Use of different inhibitory quotients to predict early virological response to tipranavir in antiretroviral-experienced human immunodeficiency virus-infected patients.
Antimicrobial agents and chemotherapy 2009;53(10):4153-8.
2009: Treviño Ana; Aguilera Antonio; Caballero Estrella; Toro Carlos; Eiros José M; Ortiz de Lejarazu Raúl; Rodríguez-Calviño Juan J; Tuset Concepción; Gómez-Hernando César; Rodríguez-Iglesias Manuel; Ramos José Manuel; Rodríguez-Díaz Juan C; Benito Rafael; Trigo Matilde; García-Campello Marta; Calderón Enrique; Garcia Juan; Rodríguez Carmen; Soriano Vincent
Seroprevalence of HTLV-1/2 infection among native and immigrant pregnant women in Spain.
AIDS research and human retroviruses 2009;25(6):551-4.
2009: Rodríguez-Nóvoa Sonia; Labarga Pablo; Soriano Vincent; Egan Deirdre; Albalater Marta; Morello Judit; Cuenca Lorena; González-Pardo Gema; Khoo Saye; Back David; Owen Andrew
Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(11):e108-16.
2009: Poveda Eva; Seclén Eduardo; González María del Mar; García Federico; Chueca Natalia; Aguilera Antonio; Rodríguez Jose Javier; González-Lahoz Juan; Soriano Vincent
Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists.
The Journal of antimicrobial chemotherapy 2009;63(5):1006-10.
2009: Morello Judit; Soriano Vincent; Blanco Francisco; Rubio Antonio J; Jiménez-Nácher Inmaculada; Rodríguez-Nóvoa Sonia
Differences in lopinavir plasma concentrations comparing Kaletra film coated tablets and soft gelatine capsules that result in various lipid abnormalities.
Drug metabolism letters 2009;3(2):67-9.
2009: Garrido Carolina; Zahonero Natalia; Corral Angélica; Arredondo Miguel; Soriano Vincent; de Mendoza Carmen
Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests.
Journal of clinical microbiology 2009;47(4):1031-6.
2009: Soriano Vincent; Tuma Paula; Vispo Eugenia; Labarga Pablo; Fernández José Vicente; Medrano José; Barreiro Pablo
Hepatitis B in HIV patients: what is the current treatment and what are the challenges?
Journal of HIV therapy 2009;14(1):13-8.
2009: Labarga Pablo; Barreiro Pablo; Martin-Carbonero Luz; Rodriguez-Novoa Sonia; Solera Carmen; Medrano Jose; Rivas Pablo; Albalater Marta; Blanco Francisco; Moreno Victoria; Vispo Eugenia; Soriano Vincent
Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir.
AIDS (London, England) 2009;23(6):689-96.
2009: Amor Aranzazu; Simón Ainhoa; Salgado María; Rodés Berta; Soriano Vincent; Toro Carlos
Lack of significant cross-reactivity for HIV-2 immunoblots in HIV-1-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2009;50(3):339-40.
2009: Rivas Pablo; Morello Judit; Garrido Carolina; Rodríguez-Nóvoa Sonia; Soriano Vincent
Role of atazanavir in the treatment of HIV infection.
Therapeutics and clinical risk management 2009;5(1):99-116.
2009: Briz Verónica; Garrido Carolina; Poveda Eva; Morello Judit; Barreiro Pablo; de Mendoza Carmen; Soriano Vincent
Raltegravir and etravirine are active against HIV type 1 group O.
AIDS research and human retroviruses 2009;25(2):225-7.
2009: Soriano Vincent; Peters Marion G; Zeuzem Stefan
New therapies for hepatitis C virus infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(3):313-20.
2009: Soriano Vincent; Peters Marion; Rockstroh Juergen
Fourth HIV & Hepatitis Coinfection Workshop; June 19-21, 2008; Madrid, Spain.
HIV clinical trials 2009;10(1):52-62.
2009: Yebra Gonzalo; Rivas Pablo; Herrero María Dolores; López Marisa; de Mulder Miguel; Puente Sabino; Ramírez-Olivencia Germán; Soriano Vincent; Holguín Africa
Clinical differences and viral diversity between newly HIV type 1-diagnosed African and non-African patients in Spain (2005-2007).
AIDS research and human retroviruses 2009;25(1):37-44.
2009: Ryan P; Blanco F; García-Gascó P; García-Merchán Ja; Vispo E; Barreiro P; Labarga P; González-Lahoz J; Soriano V
Predictors of severe hepatic steatosis using abdominal ultrasound in HIV-infected patients.
HIV medicine 2009;10(1):53-9.
2009: Vispo Eugenia; Barreiro Pablo; Del Valle José; Maida Ivana; de Ledinghen Victor; Quereda Carmen; Moreno Alberto; Macías Juan; Castera Laurent; Pineda Juan Antonio; Soriano Vincent
Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation.
Antiviral therapy 2009;14(2):187-93.
2008: Morello Judit; Rodríguez-Novoa Sonia; Jiménez-Nácher Inmaculada; Soriano Vincent
Usefulness of monitoring ribavirin plasma concentrations to improve treatment response in patients with chronic hepatitis C.
The Journal of antimicrobial chemotherapy 2008;62(6):1174-80.
2008: Vispo Eugenia; Maida Ivana; Moreno Alberto; Barreiro Pablo; Soriano Vincent
Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C.
The Journal of antimicrobial chemotherapy 2008;62(6):1470-2.
2008: Vispo Eugenia; Maida Ivana; Barreiro Pablo; Moreno Victoria; Soriano Vincent
Upper gastrointestinal bleeding may unmask didanosine-associated portal hepatopathy in HIV/HCV co-infected patients.
HIV clinical trials 2008;9(6):440-4.
2008: Rodríguez-Nóvoa Sonia; Morello Judit; González Mar; Vispo Eugenia; Barreiro Pablo; González-Pardo Gema; Jiménez-Nácher Inmaculada; Gonzalez-Lahoz Juan; Soriano Vincent
Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin.
AIDS (London, England) 2008;22(18):2535-7.
2008: Poveda Eva; de Mendoza Carmen; Pattery Theresa; González María del Mar; Villacian Jorge; Soriano Vincent
Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues.
AIDS (London, England) 2008;22(17):2395-8.
2008: Benito José M; López Mariola; Lozano Sara; González-Lahoz Juan; Soriano Vincent
Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
The Journal of infectious diseases 2008;198(10):1466-73.
2008: Soriano Vincent; Mocroft Amanda; Rockstroh Juergen; Ledergerber Bruno; Knysz Brygida; Chaplinskas Saulius; Peters Lars; Karlsson Anders; Katlama Christine; Toro Carlos; Kupfer Bernd; Vogel Martin; Lundgren Jens;
Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.
The Journal of infectious diseases 2008;198(9):1337-44.
2008: López Mariola; Rallón Norma; Soriano Vincent; Rodríguez Isabel; Valencia Eulalia; Labarga Pablo; Moreno Victoria; Vispo Eugenia; Roncal Fernando; González-Lahoz Juan; Benito José M
HIV rebound after discontinuation of antiretroviral therapy increases and expands HIV-specific CD8+ responses but has no impact on its functionality.
AIDS research and human retroviruses 2008;24(9):1197-201.
2008: López Mariola; Soriano Vincent; Lozano Sara; Ballesteros Celia; Cascajero Almudena; Rodés Berta; De La Vega Elvira; González-Lahoz Juan; Benito José M
No major differences in the functional profile of HIV Gag and Nef-specific CD8+ responses between long-term nonprogressors and typical progressors.
AIDS research and human retroviruses 2008;24(9):1185-95.
2008: Bottecchia Marcelle; Madejón Antonio; Sheldon Julie; García-Samaniego Javier; Barreiro Pablo; Soriano Vincent
Hepatitis B virus genotype A2 harbours an L217R polymorphism which may account for a lower response to adefovir.
The Journal of antimicrobial chemotherapy 2008;62(3):626-7.
2008: Soriano Vincent; Puoti Massimo; Peters Marion; Benhamou Yves; Sulkowski Mark; Zoulim Fabien; Mauss Stefan; Rockstroh Juergen
Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.
AIDS (London, England) 2008;22(12):1399-410.
2008: Briz Verónica; Poveda Eva; López Mariola; González María Del Mar; Soriano Vincent; Benito José Miguel
Impact of antiretroviral therapy on chemokine (C-C motif) receptor 5 expression in HIV patients followed for over 2 years.
AIDS (London, England) 2008;22(11):1371-4.
2008: de Mendoza Carmen; Van Baelen Kurt; Poveda Eva; Rondelez Evelien; Zahonero Natalia; Stuyver Lieven; Garrido Carolina; Villacian Jorge; Soriano Vincent;
Performance of a population-based HIV-1 tropism phenotypic assay and correlation with V3 genotypic prediction tools in recent HIV-1 seroconverters.
Journal of acquired immune deficiency syndromes (1999) 2008;48(3):241-4.
2008: Soriano Vincent; Perelson Alan S; Zoulim Fabien
Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?
The Journal of antimicrobial chemotherapy 2008;62(1):1-4.
2008: Rodríguez-Nóvoa Sonia; Morello Judit; Barreiro Pablo; Maida Ivana; García-Gascó Pilar; Vispo Eugenia; González-Pardo Gema; Parra Antonio; Jiménez-Nácher Inmaculada; Soriano Vincent
Switch from ritonavir-boosted to unboosted atazanavir guided by therapeutic drug monitoring.
AIDS research and human retroviruses 2008;24(6):821-5.
2008: de Mendoza Carmen; Jiménez-Nacher Inmaculada; Garrido Carolina; Barreiro Pablo; Poveda Eva; Corral Angélica; Zahonero Natalia; González-Lahoz Juan; Soriano Vincent
Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(11):1782-5.
2008: López Mariola; Soriano Vincent; Rallón Norma; Cascajero Almudena; González-Lahoz Juan; Benito José M
Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
European journal of immunology 2008;38(6):1548-58.
2008: Soriano Vincent; Vispo Eugenia; Bottecchia Marcelle; Sheldon Julie; Tuma Paula; Garcia-Samaniego Javier; Barreiro Pablo
Management of hepatitis B virus co-infection on and off antiretroviral therapy.
Current HIV/AIDS reports 2008;5(2):86-93.
2008: Maida I; Ríos M J; Pérez-Saleme L; Ramos B; Soriano V; Pegram P S; Mura M S; Sánchez-Margalet V; Saldívar-Cornejo I; Wilkin A; Babudieri S; Núñez M
Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era.
AIDS research and human retroviruses 2008;24(5):679-83.
2008: Núñez M; Ocampo A; Aguirrebengoa K; Cervantes M; Pascual A; Echeverria S; Asensi V; Barreiro P; Garcia-Samaniego J; Soriano V;
Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin.
Journal of viral hepatitis 2008;15(5):363-9.
2008: Medrano José; Barreiro Pablo; Tuma Paula; Vispo Eugenia; Labarga Pablo; Blanco Francisco; Soriano Vincent
Risk for immune-mediated liver reactions by nevirapine revisited.
AIDS reviews 2008;10(2):110-5.
2008: Soriano Vincent; Vispo Eugenia; Labarga Pablo; Barreiro Pablo
A low antiretroviral activity of the antihepatitis B drug entecavir may be enough to select for M184V in HIV-1.
AIDS (London, England) 2008;22(7):911-2.
2008: Sheldon Julie; Soriano Vincent
Hepatitis B virus escape mutants induced by antiviral therapy.
The Journal of antimicrobial chemotherapy 2008;61(4):766-8.
2008: Soriano Vincent; Madejon Antonio; Vispo Eugenia; Labarga Pablo; Garcia-Samaniego Javier; Martin-Carbonero Luz; Sheldon Julie; Bottecchia Marcelle; Tuma Paula; Barreiro Pablo
Emerging drugs for hepatitis C.
Expert opinion on emerging drugs 2008;13(1):1-19.
2008: Poveda Eva; de Mendoza Carmen; Parkin Neil; Choe Sunny; García-Gasco Pilar; Corral Angélica; Soriano Vincent
Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypes.
AIDS (London, England) 2008;22(5):611-6.
2008: Castellares C; Barreiro P; Martín-Carbonero L; Labarga P; Vispo M E; Casado R; Galindo L; García-Gascó P; García-Samaniego J; Soriano V
Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.
Journal of viral hepatitis 2008;15(3):165-72.
2008: Garrido Carolina; Zahonero Natalia; Fernándes Diana; Serrano Dulcelina; Silva Ana Rita; Ferraria Nelia; Antúnes Francisco; González-Lahoz Juan; Soriano Vincent; de Mendoza Carmen
Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola.
The Journal of antimicrobial chemotherapy 2008;61(3):694-8.
2008: Holguín Africa; Lospitao Eva; López Marisa; de Arellano Eva Ramírez; Pena María José; del Romero Jorge; Martín Cristina; Soriano Vincent
Genetic characterization of complex inter-recombinant HIV-1 strains circulating in Spain and reliability of distinct rapid subtyping tools.
Journal of medical virology 2008;80(3):383-91.
2008: Garrido Carolina; Roulet Vanessa; Chueca Natalia; Poveda Eva; Aguilera Antonio; Skrabal Katharina; Zahonero Natalia; Carlos Silvia; García Federico; Faudon Jean Louis; Soriano Vincent; de Mendoza Carmen
Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.
Journal of clinical microbiology 2008;46(3):887-91.
2008: García-Gascó Pilar; Maida Ivana; Blanco Francisco; Barreiro Pablo; Martín-Carbonero Luz; Vispo Eugenia; González-Lahoz Juan; Soriano Vincent
Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome.
The Journal of antimicrobial chemotherapy 2008;61(3):699-704.
2008: Briz Verónica; Poveda Eva; del Mar González María; Martín-Carbonero Luz; González-González Rocío; Soriano Vincent
Impact of antiretroviral therapy on viral tropism in HIV-infected patients followed longitudinally for over 5 years.
The Journal of antimicrobial chemotherapy 2008;61(2):405-10.
2008: Vispo Eugenia; Martinez-Alarcon José; Poveda Eva; Toro Carlos; Soriano Vincent
Initial spontaneous clearance and re-infection with a distinct hepatitis C virus genotype leading to chronic hepatitis C in an HIV+ intravenous drug user.
AIDS (London, England) 2008;22(2):318.
2008: de Mendoza Carmen; Garrido Carolina; Corral Angélica; Zahonero Natalia; Soriano Vincent
Prevalence and impact of HIV-1 protease mutation L76V on lopinavir resistance.
AIDS (London, England) 2008;22(2):311-3.
2008: Martin-Carbonero Luz; Nuñez Marina; Mariño Ana; Alcocer Federico; Bonet Llucía; García-Samaniego Javier; López-Serrano Pilar; Cordero Miguel; Portu Joseba; Soriano Vincent
Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
AIDS (London, England) 2008;22(1):15-21.
2008: Soriano Vincent; García-Gasco Pilar; Vispo Eugenia; Ruiz-Sancho Andrés; Blanco Francisco; Martín-Carbonero Luz; Rodríguez-Novoa Sonia; Morello Judit; de Mendoza Carmen; Rivas Pablo; Barreiro Pablo; González-Lahoz Juan
Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial.
The Journal of antimicrobial chemotherapy 2008;61(1):200-5.
2008: Vispo Eugenia; Barreiro Pablo; Rodriguez-Nóvoa Sonia; Morello Judit; Labarga Pablo; Martín-Carbonero Luz; Maida Ivana; García-Gascó Pilar; Soriano Vincent
Distinct hepatitis C virus kinetics in HIV-infected patients treated with ribavirin plus either pegylated interferon alpha2a or alpha2b.
Antiviral therapy 2008;13(4):511-7.
2008: Vispo Eugenia; Barreiro Pablo; Pineda Juan A; Mira José A; Maida Ivana; Martín-Carbonero Luz; Rodríguez-Nóvoa Sonia; Santos Ignacio; López-Cortes Luis F; Merino Dolores; Rivero Antonio; Soriano Vincent
Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir.
Antiviral therapy 2008;13(3):429-37.
2008: Maida Ivana; Garcia-Gasco Pilar; Sotgiu Giovanni; Rios María José; Vispo María Eugenia; Martin-Carbonero Luz; Barreiro Pablo; Mura María Stella; Babudieri Sergio; Albertos Sonia; Garcia-Samaniego Javier; Soriano Vincent
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome.
Antiviral therapy 2008;13(1):103-7.
2008: Sheldon Julie; Ramos Belén; Toro Carlos; Ríos Pilar; Martínez-Alarcón José; Bottecchia Marcelle; Romero Miriam; Garcia-Samaniego Javier; Soriano Vincent
Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Antiviral therapy 2008;13(1):97-102.
2007: Morello Judit; Rodríguez-Nóvoa Sonia; Cantillano Ana L Rendon; González-Pardo Gema; Jiménez Inmaculada; Soriano Vincent
Measurement of ribavirin plasma concentrations by high-performance liquid chromatography using a novel solid-phase extraction method in patients treated for chronic hepatitis C.
Therapeutic drug monitoring 2007;29(6):802-6.
2007: Bottecchia Marcelle; Garcia-Samaniego Javier; Soriano Vincent
The implications of antiviral drugs with activity against hepatitis B virus and HIV.
Current opinion in infectious diseases 2007;20(6):621-8.
2007: Poveda Eva; Garrido Carolina; de Mendoza Carmen; Corral Angélica; Cobo Julio; González-Lahoz Juan; Soriano Vincent
Prevalence of etravirine (TMC-125) resistance mutations in HIV-infected patients with prior experience of non-nucleoside reverse transcriptase inhibitors.
The Journal of antimicrobial chemotherapy 2007;60(6):1409-10.
2007: Poveda Eva; Vispo Eugenia; Pattery Theresa; de Mendoza Carmen; Villacian Jorge; Soriano Vincent
Impact of baseline protease genotype and phenotype on the response to darunavir outside clinical trials.
The Journal of antimicrobial chemotherapy 2007;60(6):1411-3.
2007: Soriano Vincent; Vispo Eugenia; Martin-Carbonero Luz; Labarga Pablo; Garcia-Samaniego Javier; Barreiro Pablo
Management and therapy of chronic hepatitis C in HIV.
Current opinion in HIV and AIDS 2007;2(6):482-8.
2007: Rodríguez-Nóvoa Sonia; García-Gascó Pilar; Blanco Francisco; González-Pardo Gema; Castellares Carol; Moreno Victoria; Jiménez-Nácher Inmaculada; González-Lahoz Juan; Soriano Vincent
Value of the HLA-B*5701 allele to predict abacavir hypersensitivity in Spaniards.
AIDS research and human retroviruses 2007;23(11):1374-6.
2007: Sheldon Julie; Ramos Belen; Garcia-Samaniego Javier; Rios Pilar; Bartholomeusz Angeline; Romero Miriam; Locarnini Stephen; Zoulim Fabien; Soriano Vincent
Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity.
Journal of acquired immune deficiency syndromes (1999) 2007;46(3):279-82.
2007: Toro Carlos; Blanco Francisco; García-Gascó Pilar; Sheldon Julie; Benito José M; Rallón Norma I; Soriano Vincent
Human T lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in an HIV-positive patient coinfected with human T lymphotropic virus type 2 following initiation of antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(9):e118-20.
2007: Soriano Vincent; Sheldon Julie; García-Gasco Pilar; Vispo Eugenia
Lack of anti-HIV activity of entecavir in an HIV patient coinfected with hepatitis B and delta viruses.
AIDS (London, England) 2007;21(16):2253-4.
2007: Sánchez-Conde Matilde; Palacios Rosario; Sanz José; Rodríguez-Novoa Sonia; Rivas Pablo; Santos Jesús; Sola Julio; Asensi Victor; de Mendoza Carmen; Estrada Vicente; Barreiro Pablo; González-Lahoz Juan; Jiménez-Nacher Inmaculada; Soriano Vincent
Efficacy and safety of a once daily regimen with efavirenz, lamivudine, and didanosine, with and without food, as initial therapy for HIV Infection: the ELADI study.
AIDS research and human retroviruses 2007;23(10):1237-41.
2007: Poveda Eva; de Mendoza Carmen; Martin-Carbonero Luz; Corral Angélica; Briz Verónica; González-Lahoz Juan; Soriano Vincent
Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors.
The Journal of antimicrobial chemotherapy 2007;60(4):885-8.
2007: Poveda Eva; Briz Veronica; Paraskevis Dimitrios; Barreiro Pablo; Hatzakis Angelos; Soriano Vincent
Dynamics of drug-resistant HIV-1 in plasma and peripheral blood cells in patients during and after enfuvirtide therapy.
AIDS research and human retroviruses 2007;23(9):1078-82.
2007: Toro Carlos; Aguilera Antonio; Caballero Estrella; Tuset Concepción; Alvarez Patricia; García-Campello Marta; Rodríguez-Iglesias Manuel; de Lejarazu Raúl Ortiz; Eiros José; Rodriguez Carmen; del Romero Jorge; Benito Rafael; Calderón Enrique; Santana Otilia; Amor Aránzazu; Gómez-Hernando César; García Juan; Soriano Vincent
Hospital-based surveillance for HTLV-1/2 infections in Spain.
AIDS research and human retroviruses 2007;23(9):1075-7.
2007: Holguín Africa; De Arellano Eva Ramírez; Soriano Vincent
Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants.
AIDS research and human retroviruses 2007;23(9):1067-74.
2007: Barreiro Pablo; Castilla José Antonio; Labarga Pablo; Soriano Vincent
Is natural conception a valid option for HIV-serodiscordant couples?
Human reproduction (Oxford, England) 2007;22(9):2353-8.
2007: Núñez Marina; Miralles Celia; Berdún Miguel Angel; Losada Elena; Aguirrebengoa Koldo; Ocampo Antonio; Arazo Piedad; Cervantes Manuel; de Los Santos Ignacio; San Joaquín Isabel; Echeverría Santiago; Galindo María José; Asensi Victor; Barreiro Pablo; Sola Julio; Hernandez-Burruezo Juan José; Guardiola Josep Maria; Romero Miriam; García-Samaniego Javier; Soriano Vincent;
Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial.
AIDS research and human retroviruses 2007;23(8):972-82.
2007: López Mariola; Soriano Vincent; Benito Jose Miguel
Escape mutations in HIV infection and its impact on CD8+ T cell responses.
Current molecular medicine 2007;7(5):446-58.
2007: Poveda Eva; Briz Verónica; de Mendoza Carmen; Benito José Miguel; Corral Angélica; Zahonero Natalia; Lozano Sara; González-Lahoz Juan; Soriano Vincent
Prevalence of X4 tropic HIV-1 variants in patients with differences in disease stage and exposure to antiretroviral therapy.
Journal of medical virology 2007;79(8):1040-6.
2007: Núñez Marina; Mariño Ana; Miralles Celia; Berdún Miguel A; Sola Julio; Hernandez-Burruezo Juan Jose; Galindo Maria Jose; Barreiro Pablo; Martin-Carbonero Luz; Soriano Vincent
Baseline serum hepatitis C virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-coinfected patients.
Journal of acquired immune deficiency syndromes (1999) 2007;45(4):439-44.
2007: Rivas Pablo; Herrero María Dolores; Puente Sabino; Ramírez-Olivencia Germán; Soriano Vincent
Immunizations in HIV-infected adults.
AIDS reviews 2007;9(3):173-87.
2007: de Arellano Eva Ramírez; Benito José Miguel; Soriano Vincent; López Marisa; Holguín Africa
Impact of ethnicity and HIV type 1 subtype on response to first-line antiretroviral therapy.
AIDS research and human retroviruses 2007;23(7):891-4.
2007: de Mendoza Carmen; Garrido Carolina; Corral Angelica; Ramírez-Olivencia German; Jiménez-Nacher Inmaculada; Zahonero Natalia; Gonzalez-Lahoz Juan; Soriano Vincent
Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients.
AIDS research and human retroviruses 2007;23(7):879-85.
2007: Poveda Eva; Briz Verónica; Roulet Vanessa; Del Mar González María; Faudon Jean-Louis; Skrabal Katharina; Soriano Vincent
Correlation between a phenotypic assay and three bioinformatic tools for determining HIV co-receptor use.
AIDS (London, England) 2007;21(11):1487-90.
2007: Benito J M; López M; Lozano S; Ballesteros C; González-Lahoz J; Soriano V
Hydroxyurea exerts an anti-proliferative effect on T cells but has no direct impact on cellular activation.
Clinical and experimental immunology 2007;149(1):171-7.
2007: Maida Ivana; Soriano Vincent; Barreiro Pablo; Rivas Pablo; Labarga Pablo; Núñez Marina
Liver fibrosis stage and HCV genotype distribution in HIV-HCV coinfected patients with persistently normal transaminases.
AIDS research and human retroviruses 2007;23(6):801-4.
2007: Martín-Carbonero L; Barreiro P; Jiménez-Galán G; García-Berriguete R; Núñez M; Ríos P; González-Lahoz J; Soriano V
Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis.
Journal of viral hepatitis 2007;14(6):392-5.
2007: Ramos B; Núñez M; Rendón A; Berdún M A; Losada E; Santos I; Echevarría S; Ocampo A; Miralles C; Arazo P; Barreiro P; Romero M; Labarga P; Guardiola J M; Garcia-Samaniego J; Soriano V
Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.
Journal of viral hepatitis 2007;14(6):387-91.
2007: Soriano Vincent; Puoti Massimo; Sulkowski Mark; Cargnel Antonietta; Benhamou Yves; Peters Marion; Mauss Stefan; Bräu Norbert; Hatzakis Angelos; Pol Stanislas; Rockstroh Juergen
Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.
AIDS (London, England) 2007;21(9):1073-89.
2007: Ruiz-Sancho Andrés; Sheldon Julie; Soriano Vincent
Telbivudine: a new option for the treatment of chronic hepatitis B.
Expert opinion on biological therapy 2007;7(5):751-61.
2007: Capa Laura; Soriano Vincent; García-Samaniego Javier; Nuñez Marina; Romero Miriam; Cascajero Almudena; Muñoz Fernando; González-Lahoz Juan; Benito José M
Influence of HCV genotype and co-infection with human immunodeficiency virus on CD4(+) and CD8(+) T-cell responses to hepatitis C virus.
Journal of medical virology 2007;79(5):503-10.
2007: Soriano Vincent; Barreiro Pablo; Martin-Carbonero Luz; Vispo Eugenia; Garcia-Samaniego Javier; Labarga Pablo; Gonzalez-Lahoz Juan
Update on the treatment of chronic hepatitis C in HIV-infected patients.
AIDS reviews 2007;9(2):99-113.
2007: Holguín Africa; Pena María José; Troncoso Fernando; Soriano Vincent
Introduction of non-B subtypes among Spaniards newly diagnosed with HIV type 1 in the Canary Islands.
AIDS research and human retroviruses 2007;23(4):498-502.
2007: de Mendoza Carmen; Morelló Judit; Garcia-Gascó Pilar; Rodríguez-Novoa Sonia; Soriano Vincent
Tipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients.
Expert opinion on pharmacotherapy 2007;8(6):839-50.
2007: Soriano Vincent; Barreiro Pablo; Martín-Carbonero Luz; Castellares Carol; Ruiz-Sancho Andres; Labarga Pablo; Ramos Belen; Gonzalez-Lahoz Juan
Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.
The Journal of infectious diseases 2007;195(8):1181-3.
2007: Barreiro Pablo; Rodríguez-Novoa Sonia; Labarga Pablo; Ruiz Andrés; Jiménez-Nácher Inmaculada; Martín-Carbonero Luz; Gonzalez-Lahoz Juan; Soriano Vincent
Influence of liver fibrosis stage on plasma levels of antiretroviral drugs in HIV-infected patients with chronic hepatitis C.
The Journal of infectious diseases 2007;195(7):973-9.
2007: de Mendoza Carmen; Rodriguez Carmen; García Federico; Eiros José M; Ruíz Lidia; Caballero Estrella; Aguilera Antonio; Leiva Pilar; Colomina Javier; Gutierrez Felix; del Romero Jorge; Aguero Jesús; Soriano Vincent;
Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance.
The Journal of antimicrobial chemotherapy 2007;59(4):698-704.
2007: Ramos Belén; Núñez Marina; Martín-Carbonero Luz; Sheldon Julie; Rios Pilar; Labarga Pablo; Romero Miriam; Barreiro Pablo; García-Samaniego Javier; Soriano Vincent
Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients.
Journal of acquired immune deficiency syndromes (1999) 2007;44(5):557-61.
2007: Ramírez de Arellano Eva; Martín Cristina; Soriano Vincent; Alcamí José; Holguín Africa
Genetic analysis of the long terminal repeat (LTR) promoter region in HIV-1-infected individuals with different rates of disease progression.
Virus genes 2007;34(2):111-6.
2007: Garcia-Gasco Pilar; Sheldon Julie; Soriano Vincent
Treatment of chronic hepatitis B in HIV-infected patients in 2007.
Journal of HIV therapy 2007;12(1):19-23.
2007: Ruiz-Sancho Andrés; Barreiro Pablo; Castellares Carol; Labarga Pablo; Ramos Belen; Garcia-Samaniego Javier; Gutiérrez Mayte; Soriano Vincent
Outbreak of syphilis, but not of acute hepatitis C, among HIV-infected homosexual men in Madrid.
HIV clinical trials 2007;8(2):98-101.
2007: Ramos Belen; Sheldon Julie; Ruiz-Sancho Andres; Toro Carlos; Ríos Pilar; Soriano Vincent
Prevalence and therapeutic significance of anti-interferon antibodies in hepatitis C virus/HIV-co-infected patients.
AIDS (London, England) 2007;21(5):652-3.
2007: de Mendoza Carmen; Martin-Carbonero Luz; Barreiro Pablo; de Baar Michel; Zahonero Natalia; Rodriguez-Novoa Sonia; Benito José Miguel; González-Lahoz Juan; Soriano Vincent
Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapy.
AIDS (London, England) 2007;21(5):583-8.
2007: Holguín Africa; Faudon Jean Louis; Labernardière Jean-Louis; Soriano Vincent
Susceptibility of HIV-1 non-B subtypes and recombinant variants to Enfuvirtide.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2007;38(2):176-80.
2007: Ramos Belén; Núñez Marina; Toro Carlos; Sheldon Julie; García-Samaniego Javier; Ríos Pilar; Soriano Vincent
Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: implications for HCV therapy in HCV/HIV-coinfected patients.
The Journal of infection 2007;54(2):173-9.
2007: Morello Judit; Rodriguez-Novoa Sonia; Jimenez-Nacher Inmaculada; Soriano Vincent
Drug interactions of tipranavir, a new HIV protease inhibitor.
Drug metabolism letters 2007;1(1):81-4.
2007: Sempere José M; Soriano Vincent; Benito José M
T regulatory cells and HIV infection.
AIDS reviews 2007;9(1):54-60.
2007: Rodríguez-Nóvoa Sonia; Martín-Carbonero Luz; Barreiro Pablo; González-Pardo Gema; Jiménez-Nácher Inmaculada; González-Lahoz Juan; Soriano Vincent
Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia.
AIDS (London, England) 2007;21(1):41-6.
2007: Bassani Sylvina; López Mariola; Toro Carlos; Jiménez Victoria; Sempere José M; Soriano Vincent; Benito Jose M
Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(1):105-10.
2007: Rodés Berta; Sheldon Julie; Toro Carlos; Cuevas Laureano; Pérez-Pastrana Esperanza; Herrera Inmaculada; Soriano Vincent
Quantitative detection of plasma human immunodeficiency virus type 2 subtype A RNA by the Nuclisens EasyQ Assay (version 1.1).
Journal of clinical microbiology 2007;45(1):88-92.
2007: Soriano Vincent; Miralles Celia; Berdún Miguel Angel; Losada Elena; Aguirrebengoa Koldo; Ocampo Antonio; Arazo Piedad; Cervantes Manuel; de los Santos Ignacio; San Joaquín Isabel; Echeverria Santiago; Galindo María J; Asensi Victor; Barreiro Pablo; Sola Julio; Hernandez-Burruezo Juan J; Guardiola Josep; Blanco Francisco; Martin-Carbonero Luz; García-Samaniego Javier; Nuñez Marina;
Premature treatment discontinuation in HIV/HCV-coinfected patients receiving pegylated interferon plus weight-based ribavirin.
Antiviral therapy 2007;12(4):469-76.
2007: Capa Laura; Soriano Vincent; García-Samaniego Javier; Nuñez Marina; Romero Miriam; de Mendoza Carmen; Cascajero Almudena; Muñoz Fernando; González-Lahoz Juan; Benito José M
Evolution of T-cell responses to hepatitis C virus (HCV) during pegylated interferon plus ribavirin treatment in HCV-monoinfected and in HCV/HIV-coinfected patients.
Antiviral therapy 2007;12(4):459-68.
2007: Marcelin Anne-Genevieve; Flandre Philippe; de Mendoza Carmen; Roquebert Benedicte; Peytavin Gilles; Valer Luisa; Wirden Marc; Abbas Sarah; Katlama Christine; Soriano Vincent; Calvez Vincent
Clinical validation of saquinavir/ritonavir genotypic resistance score in protease-inhibitor-experienced patients.
Antiviral therapy 2007;12(2):247-52.
2006: Martín-Carbonero Luz; Gil Paldma; García-Benayas Teresa; Barreiro Pablo; Blanco Francisco; de Mendoza Carmen; Maida Ivana; González-Lahoz Juan; Soriano Vincent
Rate of virologic failure and selection of drug resistance mutations using different triple nucleos(t)ide analogue combinations in HIV-infected patients.
AIDS research and human retroviruses 2006;22(12):1231-5.
2006: Toro Carlos; Jiménez Victoria; Rodríguez Carmen; Del Romero Jorge; Rodés Berta; Holguín Africa; Alvarez Patricia; García-Campello Marta; Gómez-Hernando César; Guelar Ana; Sheldon Julie; de Mendoza Carmen; Simón Ainhoa; Soriano Vincent
Molecular and epidemiological characteristics of blood-borne virus infections among recent immigrants in Spain.
Journal of medical virology 2006;78(12):1599-608.
2006: Soriano Vincent; Labarga Pablo; Ruiz-Sancho Andrés; Garcia-Samaniego Javier; Barreiro Pablo
Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin.
AIDS (London, England) 2006;20(17):2225-7.
2006: Núñez Marina; Soriano Vincent; López Mariola; Ballesteros Celia; Cascajero Almudena; González-Lahoz Juan; Benito Jose Miguel
Coinfection with hepatitis C virus increases lymphocyte apoptosis in HIV-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(9):1209-12.
2006: Barreiro Pablo; del Romero Jorge; Leal Manuel; Hernando Victoria; Asencio Román; de Mendoza Carmen; Labarga Pablo; Núñez Marina; Ramos José Tomás; González-Lahoz Juan; Soriano Vincent;
Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2006;43(3):324-6.
2006: Schmutz Guenther; Nelson Mark; Lutz Thomas; Sheldon Julie; Bruno Raffaele; von Boemmel Florian; Hoffmann Christian; Rockstroh Juergen; Stoehr Albrecht; Wolf Eva; Soriano Vincent; Berger Florian; Berg Thomas; Carlebach Amina; Schwarze-Zander Carolynne; Schürmann Dirk; Jaeger Hans; Mauss Stefan
Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection.
AIDS (London, England) 2006;20(15):1951-4.
2006: Maida Ivana; Soriano Vincent; Castellares Carol; Ramos Belén; Sotgiu Giovanni; Martin-Carbonero Luz; Barreiro Pablo; Rivas Pablo; González-Lahoz Juan; Núñez Marina
Liver fibrosis in HIV-infected patients with chronic hepatitis B extensively exposed to antiretroviral therapy with anti-HBV activity.
HIV clinical trials 2006;7(5):246-50.
2006: López Mariola; Soriano Vincent; Lozano Sara; Martinez Pilar; Sempere José; González-Lahoz Juan; Benito José
Impact of Gag sequence variability on level, phenotype, and function of anti-HIV Gag-specific CD8(+) cytotoxic T lymphocytes in untreated chronically HIV-infected patients.
AIDS research and human retroviruses 2006;22(9):884-92.
2006: Núñez Marina; Ramos Belén; Díaz-Pollán Beatriz; Camino Nuria; Martín-Carbonero Luz; Barreiro Pablo; González-Lahoz Juan; Soriano Vincent
Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy.
AIDS research and human retroviruses 2006;22(9):842-8.
2006: Núñez María José; Martín-Carbonero Luz; Moreno Victoria; Valencia Eulalia; Garcia-Samaniego Javier; Castillo Juan González Del; Barreiro Pablo; González-Lahoz Juan; Soriano Vincent
Impact of antiretroviral treatment-related toxicities on hospital admissions in HIV-infected patients.
AIDS research and human retroviruses 2006;22(9):825-9.
2006: Benito José Miguel; López Mariola; Ballesteros Celia; Lozano Sara; Capa Laura; Barreiro Pablo; Sempere José; Gonzalez-Lahoz Juan; Soriano Vincent
Immunological and virological effects of structured treatment interruptions following exposure to hydroxyurea plus didanosine.
AIDS research and human retroviruses 2006;22(8):734-43.
2006: Holguín Africa; Suñe Carlos; Hamy François; Soriano Vincent; Klimkait Thomas
Natural polymorphisms in the protease gene modulate the replicative capacity of non-B HIV-1 variants in the absence of drug pressure.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;36(4):264-71.
2006: Barreiro Pablo; Duerr Ann; Beckerman Karen; Soriano Vincent
Reproductive options for HIV-serodiscordant couples.
AIDS reviews 2006;8(3):158-70.
2006: de Mendoza Carmen; Valer Luisa; Ribera Esteve; Barreiro Pablo; Martín-Carbonero Luz; Ramirez German; Soriano Vincent
Performance of six different ritonavir-boosted protease inhibitor-based regimens in heavily antiretroviral-experienced HIV-infected patients.
HIV clinical trials 2006;7(4):163-71.
2006: Poveda Eva; Blanco Francisco; García-Gascó Pilar; Alcolea Antonio; Briz Verónica; Soriano Vincent
Successful rescue therapy with darunabir (TMC114) in HIV-infected patients who have failed several ritonavir-boosted protease inhibitors.
AIDS (London, England) 2006;20(11):1558-60.
2006: Sheldon J; Rodès B; Zoulim F; Bartholomeusz A; Soriano V
Mutations affecting the replication capacity of the hepatitis B virus.
Journal of viral hepatitis 2006;13(7):427-34.
2006: Rodríguez-Nóvoa S; Barreiro P; Jiménez-Nácher I; Soriano V
Overview of the pharmacogenetics of HIV therapy.
The pharmacogenomics journal 2006;6(4):234-45.
2006: Amor Aranzazu; Toro Carlos; Jiménez Victoria; Simón Ainhoa; Ramos Belén; Soriano Vincent
Seroreversion of HIV antibodies in patients with prolonged suppression of viraemia under HAART.
AIDS (London, England) 2006;20(10):1460-2.
2006: Poveda Eva; Briz Verónica; Quiñones-Mateu Miguel; Soriano Vincent
HIV tropism: diagnostic tools and implications for disease progression and treatment with entry inhibitors.
AIDS (London, England) 2006;20(10):1359-67.
2006: Maida Ivana; Núñez Marina; Ríos Maria Jose; Martín-Carbonero Luz; Sotgiu Giovanni; Toro Carlos; Rivas Pablo; Barreiro Pablo; Mura Maria Stella; Babudieri Sergio; Garcia-Samaniego Javier; González-Lahoz Juan; Soriano Vincent
Severe liver disease associated with prolonged exposure to antiretroviral drugs.
Journal of acquired immune deficiency syndromes (1999) 2006;42(2):177-82.
2006: Soriano Vincent; Barreiro Pablo; Nuñez Marina
Management of chronic hepatitis B and C in HIV-coinfected patients.
The Journal of antimicrobial chemotherapy 2006;57(5):815-8.
2006: Barreiro Pablo; Soriano Vincent
Suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir.
The Journal of antimicrobial chemotherapy 2006;57(5):806-9.
2006: Holguín Africa; Ramirez de Arellano Eva; Rivas Pablo; Soriano Vincent
Efficacy of antiretroviral therapy in individuals infected with HIV-1 non-B subtypes.
AIDS reviews 2006;8(2):98-107.
2006: García-Benayas Teresa; Rendón Ana Lucía; Rodríguez-Novóa Sonia; Barrios Ana; Maida Ivana; Blanco Francisco; Barreiro Pablo; Rivas Pablo; González-Lahoz Juan; Soriano Vincent
Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir.
AIDS research and human retroviruses 2006;22(4):333-7.
2006: de Mendoza Carmen; Valer Luisa; Bacheler Lee; Pattery Theresa; Corral Angélica; Soriano Vincent
Prevalence of the HIV-1 protease mutation I47A in clinical practice and association with lopinavir resistance.
AIDS (London, England) 2006;20(7):1071-4.
2006: Barreiro Pablo; Martín-Carbonero Luz; Núñez Marina; Rivas Pablo; Morente Adolfo; Simarro Nuria; Labarga Pablo; González-Lahoz Juan; Soriano Vincent
Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(7):1032-9.
2006: Rodés Berta; Sheldon Julie; Toro Carlos; Jiménez Victoria; Alvarez Miguel Angel; Soriano Vincent
Susceptibility to protease inhibitors in HIV-2 primary isolates from patients failing antiretroviral therapy.
The Journal of antimicrobial chemotherapy 2006;57(4):709-13.
2006: Briz Verónica; Poveda Eva; Soriano Vincent
HIV entry inhibitors: mechanisms of action and resistance pathways.
The Journal of antimicrobial chemotherapy 2006;57(4):619-27.
2006: Soriano Vincent; Nuñez Marina; Garcia-Samaniego Javier; Labarga Pablo; Simarro Nuria; Martín-Carbonero Luz; Romero Miriam; Ramos Belen; Barreiro Pablo
Chronic hepatitis C in HIV-infected patients: those who more need therapy are those who respond less.
Infectious disorders drug targets 2006;6(1):57-88.
2006: Holguín Africa; Alvarez Amparo; Soriano Vincent
Variability in the P6gag domains of HIV-1 involved in viral budding.
AIDS (London, England) 2006;20(4):624-7.
2006: Ramírez de Arellano Eva; Soriano Vincent; Alcamil José; Holguín Africa
New findings on transcription regulation across different HIV-1 subtypes.
AIDS reviews 2006;8(1):9-16.
2006: Bassani Sylvina; Toro Carlos; Jiménez Victoria; Rodés Berta; Soriano Vincent
Can the level of immunosuppression in human immunodeficiency virus-infected patients affect the reliability of human T-cell lymphotropic virus type 2 serological diagnosis?
Clinical and vaccine immunology : CVI 2006;13(1):160-1.
2006: Rodríguez Nóvoa Sonia; Barreiro Pablo; Rendón Ana; Barrios Ana; Corral Angélica; Jiménez-Nacher Inmaculada; González-Lahoz Juan; Soriano Vincent
Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(2):291-5.
2006: Rodés Berta; Toro Carlos; Sheldon Julie A; Jiménez Victoria; Mansinho Kamal; Soriano Vincent
High rate of proV47A selection in HIV-2 patients failing lopinavir-based HAART.
AIDS (London, England) 2006;20(1):127-9.
2006: Barreiro Pablo; Labarga Pablo; Martín-Carbonero Luz; Amor Aranzazu; Ruiz-Sancho Andrés; Castellares Carol; González-Lahoz Juan; Soriano Vincent
Sustained virological response following HCV therapy is associated with non-progression of liver fibrosis in HCV/HIV-coinfected patients.
Antiviral therapy 2006;11(7):869-77.
2006: Soriano Vincent
Treatment of chronic hepatitis C in HIV-positive individuals: selection of candidates.
Journal of hepatology 2006;44(1 Suppl):S44-8.
2005: García-Gasco Pilar; Blanco Francisco; Soriano Vincent
Integrase inhibitors.
Journal of HIV therapy 2005;10(4):75-8.
2005: Soriano Vincent; Nuñez Marina; Sheldon Julie; Ramos Belen; Garcia-Samaniego Javier; Martín-Carbonero Luz; Maida Ivana; Gonzalez-Lahoz Juan
Complications in treating chronic hepatitis B in patients with HIV.
Expert opinion on pharmacotherapy 2005;6(16):2831-42.
2005: Benito Jose M; Lopez Mariola; Lozano Sara; Ballesteros Celia; Capa Laura; Martinez Pilar; Gonzalez-Lahoz Juan; Soriano Vincent
CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation.
The Journal of infectious diseases 2005;192(12):2142-6.
2005: Poveda Eva; Rodés Berta; Lebel-Binay Sophie; Faudon Jean-Louis; Jimenez Victoria; Soriano Vincent
Dynamics of enfuvirtide resistance in HIV-infected patients during and after long-term enfuvirtide salvage therapy.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;34(4):295-301.
2005: Soriano Vincent; Martin-Carbonero Luz; Maida Ivana; Garcia-Samaniego Javier; Nuñez Marina
New paradigms in the management of HIV and hepatitis C virus coinfection.
Current opinion in infectious diseases 2005;18(6):550-60.
2005: Valer Luisa; de Mendoza Carmen; Soriano Vincent
Predictive value of drug levels, HIV genotyping, and the genotypic inhibitory quotient (GIQ) on response to saquinavir/ritonavir in antiretroviral-experienced HIV-infected patients.
Journal of medical virology 2005;77(4):460-4.
2005: Maida Ivana; Soriano Vincent; Ramos Belén; Ríos Pilar; González-Lahoz Juan; Núñez Marina
Characteristics and prospects for hepatitis C therapy of an HIV-HCV coinfected population followed at a reference HIV center.
HIV clinical trials 2005;6(6):329-36.
2005: De Arellano Eva Ramírez; Soriano Vincent; Holguín Africa
Genetic analysis of regulatory, promoter, and TAR regions of LTR sequences belonging to HIV type 1 Non-B subtypes.
AIDS research and human retroviruses 2005;21(11):949-54.
2005: Sheldon Julie A; Corral Angélica; Rodés Berta; Mauss Stefan; Rockstroh Juergen; Berger Florian; Schwarze-Zander Carolynne; Soriano Vincent
Risk of selecting K65R in antiretroviral-naive HIV-infected individuals with chronic hepatitis B treated with adefovir.
AIDS (London, England) 2005;19(17):2036-8.
2005: de Mendoza Carmen; Rodriguez Carmen; Colomina Javier; Tuset Concepcion; Garcia Federico; Eiros Jose M; Corral Angelica; Leiva Pilar; Aguero Jesus; Torre-Cisneros Julian; Pedreira Jose; Viciana Isabel; del Romero Jorge; Saez Ana; Ortiz de Lejarazu Raul; Soriano Vincent;
Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(9):1350-4.
2005: Holguín Africa; Alvarez Amparo; Soriano Vincent
Differences in the length of gag proteins among different HIV type 1 subtypes.
AIDS research and human retroviruses 2005;21(10):886-93.
2005: Soriano Vincent; Ramos Belen; Nunez Marina; Barreiro Pablo; Maida Ivana; Garcia-Samaniego Javier; Gonzalez-Lahoz Juan
Failure of hepatitis C therapy in HIV-coinfected drug users is not due to a shift in hepatitis C virus genotype.
The Journal of infectious diseases 2005;192(7):1245-8.
2005: Sánchez-Conde Matilde; Gil Paloma; Sánchez-Somolinos Mar; Gonzalez-Lahoz Juan; Soriano Vincent
Hepatic and renal safety profile of tenofovir in HIV-infected patients with hepatitis C, including patients on interferon plus ribavirin.
HIV clinical trials 2005;6(5):278-80.
2005: Rendón Al; Núñez M; Jiménez-Nácher I; González de Requena D; González-Lahoz J; Soriano V
Clinical benefit of interventions driven by therapeutic drug monitoring.
HIV medicine 2005;6(5):360-5.
2005: Barreiro Pablo; de Mendoza Carmen; González-Lahoz Juan; Soriano Vincent
Superiority of protease inhibitors over nonnucleoside reverse-transcriptase inhibitors when highly active antiretroviral therapy is resumed after treatment interruption.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(6):897-900.
2005: Rodes Berta; García Federico; Gutierrez Carolina; Martinez-Picado Javier; Aguilera Antonio; Saumoy Maria; Vallejo Alex; Domingo Pere; Dalmau David; Ribas Maria Angels; Blanco José Luis; Pedreira José; Perez-Elias Maria Jesús; Leal Manuel; de Mendoza Carmen; Soriano Vincent;
Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
Journal of medical virology 2005;77(1):23-8.
2005: Barreiro Pablo; Jiménez-Nácher Inmaculada; García Benito; García-Benayas Teresa; Rivas Pablo; Soriano Vincent
Nucleoside/nucleotide backbones for the treatment of HIV infection.
Current opinion in investigational drugs (London, England : 2000) 2005;6(8):812-22.
2005: Rendón Ana Lucía; Núñez Marina; Romero Miriam; Barreiro Pablo; Martín-Carbonero Luz; García-Samaniego Javier; Jiménez-Nácher Inmaculada; González-Lahoz Juan; Soriano Vincent
Early monitoring of ribavirin plasma concentrations may predict anemia and early virologic response in HIV/hepatitis C virus-coinfected patients.
Journal of acquired immune deficiency syndromes (1999) 2005;39(4):401-5.
2005: Poveda Eva; Briz Verónica; Soriano Vincent
Enfuvirtide, the first fusion inhibitor to treat HIV infection.
AIDS reviews 2005;7(3):139-47.
2005: Sánchez-Conde Matilde; de Mendoza Carmen; Jiménez-Nacher Inmaculada; Barreiro Pablo; Gonzalez-Lahoz Juan; Soriano Vincent
Reductions in stavudine dose might ameliorate mitochondrial-associated complications without compromising antiviral activity.
HIV clinical trials 2005;6(4):197-202.
2005: Núñez Marina; Soriano Vincent
Current concepts in the management and treatment of hepatitis C in HIV-infected patients.
Annals of hepatology : official journal of the Mexican Association of Hepatology 2005;4(3):151-60.
2005: Rodes Berta; de Mendoza Carmen; Rodgers Mette; Newell Anthony; Jimenez Victoria; Lopez-Brugada Rosa Maria; Soriano Vincent
Treatment response and drug resistance in patients infected with HIV type 1 group O viruses.
AIDS research and human retroviruses 2005;21(7):602-7.
2005: de Mendoza Carmen; Rodriguez Carmen; Eiros José Maria; Colomina Javier; Garcia Federico; Leiva Pilar; Torre-Cisneros Julián; Aguero Jesús; Pedreira José; Viciana Isabel; Corral Angélica; del Romero Jorge; Ortiz de Lejarazu Raúl; Soriano Vincent
Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(2):227-32.
2005: Rodés Berta; Toro Carlos; Jiménez Victoria; Soriano Vincent
Viral response to antiretroviral therapy in a patient coinfected with HIV type 1 and type 2.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(2):e19-21.
2005: de Mendoza C; Koppelman M; Montès B; Ferre V; Soriano V; Cuypers H; Segondy M; Oosterlaken T
Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma.
Journal of virological methods 2005;127(1):54-9.
2005: Poveda Eva; Barreiro Pablo; Rodés Berta; Soriano Vincent
Enfuvirtide is active against HIV type 1 group O.
AIDS research and human retroviruses 2005;21(6):583-5.
2005: De Requena Daniel González; Jiménez-Nácher Inmaculada; Soriano Vincent
Changes in nevirapine plasma concentrations over time and its relationship with liver enzyme elevations.
AIDS research and human retroviruses 2005;21(6):555-9.
2005: Núñez Marina; Soriano Vincent
Management of patients co-infected with hepatitis B virus and HIV.
The Lancet infectious diseases 2005;5(6):374-82.
2005: Toro Carlos; Benito Rafael; Aguilera Antonio; Bassani Sylvina; Rodríguez Carmen; Calderón Enrique; Caballero Estrella; Alvarez Patricia; García Juan; Rodríguez-Iglesias Manuel; Guelar Ana; del Romero Jorge; Soriano Vincent;
Infection with human T lymphotropic virus type I in organ transplant donors and recipients in Spain.
Journal of medical virology 2005;76(2):268-70.
2005: Rodriguez-Novoa Sonia; Barreiro Pablo; Rendón Ana; Jiménez-Nacher Inmaculada; González-Lahoz Juan; Soriano Vincent
Influence of 516G>T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjects.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(9):1358-61.
2005: Toro Carlos; Rodés Berta; Bassani Sylvina; Jiménez Victoria; Tuset Concepción; Brugal María Teresa; de la Fuente Luis; Soriano Vincent;
Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;33(1):65-70.
2005: de Mendoza Carmen; Martín-Carbonero Luz; Gallego Oscar; Corral Angélica; González-Lahoz Juan; Soriano Vincent
Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection.
Journal of medical virology 2005;76(1):1-6.
2005: Rodríguez-Nóvoa Sonia; Barreiro Pablo; Jiménez-Nacher Inmaculada; Rendón Ana; Soriano Vincent
Pharmacogenetics in HIV therapy.
AIDS reviews 2005;7(2):103-12.
2005: Toro Carlos; Bassani Sylvina; Ríos Pilar; Jiménez Victoria; Camino Nuria; Soriano Vincent
Influence of HTLV-2 infection on hepatitis C virus replication in HIV-positive patients.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;32(4):338-9.
2005: Benito José Miguel; López Mariola; Lozano Sara; Ballesteros Celia; Martinez Pilar; González-Lahoz Juan; Soriano Vincent
Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2005;38(4):373-81.
2005: Núñez Marina; Maida Ivana; Babudieri Sergio; Fenu Luisa; Camino Nuria; González-Lahoz Juan; Mura Maria Stella; Soriano Vincent
Hepatitis C viremia in HIV/HCV-coinfected patients: lower levels in presence of chronic hepatitis B.
HIV clinical trials 2005;6(2):103-6.
2005: Martin-Carbonero Luz; Soriano Vincent
Interplay between hepatitis C, liver steatosis and antiretroviral therapy in HIV-infected patients.
AIDS (London, England) 2005;19(6):621-3.
2005: Barrios Ana; Rendón Ana; Negredo Eugenia; Barreiro Pablo; Garcia-Benayas Teresa; Labarga Pablo; Santos Jesús; Domingo Pere; Sánchez-Conde Matilde; Maida Ivana; Martín-Carbonero Luz; Núñez Marina; Blanco Francisco; Clotet Bonaventura; Sambeat Maria Antonia; Gil Paloma; Gonzalez-Lahoz Juan; Cooper David; Soriano Vincent
Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine.
AIDS (London, England) 2005;19(6):569-75.
2005: Holguín Africa; Alvarez Amparo; Soriano Vincent
Heterogeneous nature of HIV-1 recombinants spreading in Spain.
Journal of medical virology 2005;75(3):374-80.
2005: Li Ming; Song Ruiguang; Masciotra Silvina; Soriano Vincent; Spira Thomas J; Lal Renu B; Yang Chunfu
Association of CCR5 human haplogroup E with rapid HIV type 1 disease progression.
AIDS research and human retroviruses 2005;21(2):111-5.
2005: Soriano Vincent; Puoti Massimo; Bonacini Maurizio; Brook Gary; Cargnel Antonietta; Rockstroh Juergen; Thio Chloe; Benhamou Yves
Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel.
AIDS (London, England) 2005;19(3):221-40.
2005: Gallego Oscar; de Mendoza Carmen; Corral Angélica; Barrios Ana; Soriano Vincent
Estimated extent of cross-resistance to ritonavir-boosted protease inhibitors among protease inhibitors-experienced patients: implications for tipranavir use.
AIDS patient care and STDs 2005;19(2):67-9.
2005: Barreiro Pablo; Rendón Ana; Rodríguez-Nóvoa Sonia; Soriano Vincent
Atazanavir: the advent of a new generation of more convenient protease inhibitors.
HIV clinical trials 2005;6(1):50-61.
2005: Barrios Ana; Negredo Eugenia; Domingo Pere; Estrada Vicente; Labarga Pablo; Asensi Víctor; Morales Dolores; Santos Jesús; Clotet Bonaventura; Soriano Vincent;
Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial.
Antiviral therapy 2005;10(7):825-32.
2005: Sheldon Julie; Camino Nuria; Rodés Berta; Bartholomeusz Angeline; Kuiper Michael; Tacke Frank; Núñez Marina; Mauss Stefan; Lutz Thomas; Klausen Gerd; Locarnini Stephen; Soriano Vincent
Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir.
Antiviral therapy 2005;10(6):727-34.
2005: Núnez Marina; Camino Nuria; Ramos Belén; Berdún Miguel Angel; Barreiro Pablo; Losada Elena; Santos Ignacio; Echevarría Santiago; Ocampo Antonio; Miralles Celia; Arazo Piedad; Martín-Carbonero Luz; Romero Miriam; García-Samaniego Javier; Soriano Vincent
Impact of ribavirin exposure on early virological response to hepatitis C therapy in HIV-infected patients with chronic hepatitis C.
Antiviral therapy 2005;10(5):657-62.
2005: de Mendoza Carmen; Soriano Vincent
The role of hepatitis C virus (HCV) in mitochondrial DNA damage in HIV/HCV-coinfected individuals.
Antiviral therapy 2005;10 Suppl 2():M109-15.
2005: de Mendoza Carmen; Sánchez-Conde Matilde; Timmermans Eveline; Buitelaar Marije; de Baar Michel P; Gonzalez-Lahoz Juan; Soriano Vincent
Mitochondrial DNA depletion in HIV-infected patients is more pronounced with chronic hepatitis C and enhanced following treatment with pegylated interferon plus ribavirin.
Antiviral therapy 2005;10(4):557-61.
2005: Soriano Vincent; Núñez Marina; Sánchez-Conde Matilde; Barreiro Pablo; García-Samaniego Javier; Martín-Carbonero Luz; Romero Miriam; González-Lahoz Juan
Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4.
Antiviral therapy 2005;10(1):167-70.
2005: Núñez Marina; Soriano Vincent
Hepatotoxicity of antiretrovirals: incidence, mechanisms and management.
Drug safety : an international journal of medical toxicology and drug experience 2005;28(1):53-66.
2004: Soriano Vincent; Maida Ivana; Núñez Marina; García-Samaniego Javier; Barreiro Pablo; Martín-Carbonero Luz; González-Lahoz Juan
Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies.
Antiviral therapy 2004;9(6):987-92.
2004: García-Benayas Teresa; Blanco Francisco; Alcolea Antonio; Cruz Juan José De La; González-Lahoz Juan; Soriano Vincent
Short communication: benefits in the lipid profile after substitution of abacavir for Stavudine: a 48-week prospective study.
AIDS research and human retroviruses 2004;20(12):1289-92.
2004: Holguín Africa; Paxinos Ellen; Hertogs Kurt; Womac Chad; Soriano Vincent
Impact of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitors in HIV-1 non-B subtypes.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;31(3):215-20.
2004: Barreiro Pablo; García-Benayas Teresa; Rendón Ana; Rodríguez-Novoa Sonia; Soriano Vincent
Combinations of nucleoside/nucleotide analogues for HIV therapy.
AIDS reviews 2004;6(4):234-43.
2004: Valer Luisa; Martín-Carbonero Luz; de Mendoza Carmen; Corral Angélica; Soriano Vincent
Predictors of selection of K65R: tenofovir use and lack of thymidine analogue mutations.
AIDS (London, England) 2004;18(15):2094-6.
2004: González de Requena Daniel; Gallego Oscar; Corral Angélica; Jiménez-Nácher Inmaculada; Soriano Vincent
Higher efavirenz concentrations determine the response to viruses carrying non-nucleoside reverse transcriptase resistance mutations.
AIDS (London, England) 2004;18(15):2091-4.
2004: de Mendoza Carmen; Rodriguez Carmen; Corral Angélica; del Romero Jorge; Gallego Oscar; Soriano Vincent
Evidence for differences in the sexual transmission efficiency of HIV strains with distinct drug resistance genotypes.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(8):1231-8.
2004: Gallego Oscar; Martin-Carbonero Luz; Aguero Jesus; de Mendoza Carmen; Corral Angelica; Soriano Vincent
Correlation between rules-based interpretation and virtual phenotype interpretation of HIV-1 genotypes for predicting drug resistance in HIV-infected individuals.
Journal of virological methods 2004;121(1):115-8.
2004: Poveda Eva; Rodés Berta; Labernardière Jean-Louis; Benito José Miguel; Toro Carlos; González-Lahoz Juan; Faudon Jean-Louis; Clavel François; Schapiro Jonathan; Soriano Vincent
Evolution of genotypic and phenotypic resistance to Enfuvirtide in HIV-infected patients experiencing prolonged virologic failure.
Journal of medical virology 2004;74(1):21-8.
2004: Soriano Vincent; Núñez Marina; Camino Nuria; Maida Ivana; Barreiro Pablo; Romero Miriam; Martin-Carbonero Luz; Garcia-Samaniego Javier; González-Lahoz Juan
Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
Antiviral therapy 2004;9(4):505-9.
2004: de Mendoza Carmen; Soriano Vincent
Resistance to HIV protease inhibitors: mechanisms and clinical consequences.
Current drug metabolism 2004;5(4):321-8.
2004: Maida Ivana; Nuñez Marina; Soriano Vincent
Triple-nucleoside regimens versus efavirenz.
The New England journal of medicine 2004;351(7):717-9; author reply 717-9.
2004: Barrios Ana; Rendón Ana Lucía; Gallego Oscar; Martín-Carbonero Luz; Valer Luisa; Ríos Pilar; Maida Ivana; García-Benayas Teresa; Jiménez-Nácher Inmaculada; González-Lahoz Juan; Soriano Vincent
Predictors of virological response to atazanavir in protease inhibitor-experienced patients.
HIV clinical trials 2004;5(4):201-5.
2004: González-Requena Daniel; Núñez Marina; Jiménez-Nacher Inmaculada; González-Lahoz Juan; Soriano Vincent
Short communication: liver toxicity of lopinavir-containing regimens in HIV-infected patients with or without hepatitis C coinfection.
AIDS research and human retroviruses 2004;20(7):698-700.
2004: López Mariola; Benito José M; Lozano Sara; Barreiro Pablo; Martínez Pilar; González-Lahoz Juan; Soriano Vincent
Enhanced HIV-specific immune responses in chronically HIV-infected patients receiving didanosine plus hydroxyurea.
AIDS (London, England) 2004;18(9):1251-61.
2004: Barreiro Pablo; Corbatón Arturo; Núñez Marina; González-Lahoz Juan; Soriano Vincent
Tolerance of didanosine as enteric-coated capsules versus buffered tablets.
AIDS patient care and STDs 2004;18(6):329-31.
2004: Carlos Martín Juan; Castilla Jesús; López Mariola; Arranz Rocío; González-Lahoz Juan; Soriano Vincent
Impact of chronic hepatitis C on HIV-1 disease progression.
HIV clinical trials 2004;5(3):125-31.
2004: Rodés Berta; Toro Carlos; Paxinos Ellen; Poveda Eva; Martinez-Padial Manuel; Benito José Miguel; Jimenez Victoria; Wrin Terri; Bassani Sylvina; Soriano Vincent
Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection.
AIDS (London, England) 2004;18(8):1109-16.
2004: Benito José Miguel; López Mariola; Soriano Vincent
The role of CD8+ T-cell response in HIV infection.
AIDS reviews 2004;6(2):79-88.
2004: Soriano Vincent; Pérez-Olmeda Mayte; Ríos Pilar; Núñez Marina; García-Samaniego Javier; González-Lahoz Juan
Hepatitis C virus (HCV) relapses after anti-HCV therapy are more frequent in HIV-infected patients.
AIDS research and human retroviruses 2004;20(4):351-3.
2004: Barrios Ana; García-Benayas Teresa; González-Lahoz Juan; Soriano Vincent
Tenofovir-related nephrotoxicity in HIV-infected patients.
AIDS (London, England) 2004;18(6):960-3.
2004: Camino N; Sheldon J; Soriano V
Update on hepatitis C treatment in HIV-coinfected patients.
Minerva gastroenterologica e dietologica 2004;50(1):67-77.
2004: Poveda Eva; Rodes Berta; Toro Carlos; Soriano Vincent
Are fusion inhibitors active against all HIV variants?
AIDS research and human retroviruses 2004;20(3):347-8.
2004: González de Requena Daniel; Gallego Oscar; Valer Luisa; Jiménez-Nácher Inmaculada; Soriano Vincent
Prediction of virological response to lopinavir/ritonavir using the genotypic inhibitory quotient.
AIDS research and human retroviruses 2004;20(3):275-8.
2004: de Mendoza Carmen; de Ronde Anthony; Smolders Karlijn; Blanco Francisco; Garcia-Benayas Teresa; de Baar Michel; Fernández-Casas Paloma; González-Lahoz Juan; Soriano Vincent
Changes in mitochondrial DNA copy number in blood cells from HIV-infected patients undergoing antiretroviral therapy.
AIDS research and human retroviruses 2004;20(3):271-3.
2004: Gallego Oscar; de Mendoza Carmen; Corral Angélica; Soriano Vincent
Prevalence of drug resistance genotypes causing broad cross-resistance to nucleos(t)ide analogues.
AIDS (London, England) 2004;18(4):689-90.
2004: Pieniazek Danuta; Rayfield Mark; Hu Dale J; Nkengasong John N; Soriano Vincent; Heneine Walid; Zeh Clement; Agwale Simon M; Wambebe Charles; Odama Liliana; Wiktor Stefan Z
HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1.
AIDS (London, England) 2004;18(3):495-502.
2004: Benito José Miguel; López Mariola; Lozano Sara; Martinez Pilar; González-Lahoz Juan; Soriano Vincent
CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy.
AIDS research and human retroviruses 2004;20(2):227-33.
2004: de Mendoza Carmen; Paxinos Ellen; Barreiro Pablo; Camino Nuria; Núñez Marina; Soriano Vincent
Different viral rebound following discontinuation of antiretroviral therapy in cases of infection with viruses carrying L74V or thymidine-associated mutations.
Journal of clinical microbiology 2004;42(2):862-6.
2004: Gallego Lucía; Barreiro Pablo; del Río Rafael; González de Requena Daniel; Rodríguez-Albariño Apolinar; González-Lahoz Juan; Soriano Vincent
Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(3):430-2.
2004: Valer Luisa; González de Requena Daniel; de Mendoza Carmen; Martin-Carbonero Luz; González-Lahoz Juan; Soriano Vincent
Impact of drug levels and baseline genotype and phenotype on the virologic response to amprenavir/ritonavir-based salvage regimens.
AIDS patient care and STDs 2004;18(1):1-6.
2004: Martín-Carbonero Luz; Benhamou Yves; Puoti Massimo; Berenguer Juan; Mallolas José; Quereda Carmen; Arizcorreta Ana; Gonzalez Antonio; Rockstroh Jurgen; Asensi Victor; Miralles Pilar; Laguno Montse; Moreno Leonor; Girón José Antonio; Vogel Martin; García-Samaniego Javier; Nuñez Marina; Romero Miriam; Moreno Santiago; de la Cruz Juan José; Soriano Vincent
Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(1):128-33.
2003: Núñez Marina; Puoti Massimo; Camino Nuria; Soriano Vincent
Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(12):1678-85.
2003: Gallego Oscar; d Mendoza Carmen; Labarga Pablo; Altisent Carmen; González Juan; García-Alcalde Isabel; Valer Luisa; Valencia Eulalia; Soriano Vincent
Long-term outcome of HIV-infected patients with multinucleoside-resistant genotypes.
HIV clinical trials 2003;4(6):372-81.
2003: Barreiro Pablo; de Mendoza Carmen; Camino Nuria; García-Benayas Teresa; Blanco Francisco; Núñez Marina; González-Lahoz Juan; Soriano Vincent
Hydroxyurea plus didanosine as maintenance therapy for HIV-infected patients on long-term successful highly active antiretroviral therapy.
HIV clinical trials 2003;4(6):361-71.
2003: Benito José M; López Mariola; Lozano Sara; Martinez Pilar; Kuroda Marcelo; González-Lahoz Juan; Soriano Vincent
Phenotype and functional characteristics of HIV-specific cytotoxic CD8+ T cells in chronically infected patients: dual effects of highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2003;34(3):255-66.
2003: Rendón Ana Lucía; Núñez Marina; González-Requena Daniel; Jiménez-Nácher Inmaculada; González-Lahoz Juan; Soriano Vincent
Diarrhea related to lopinavir is most often mild and not related to plasma drug levels.
Journal of acquired immune deficiency syndromes (1999) 2003;34(2):247.
2003: González de Requena Daniel; Blanco Francisco; Garcia-Benayas Teresa; Jiménez-Nácher Inmaculada; González-Lahoz Juan; Soriano Vincent
Correlation between lopinavir plasma levels and lipid abnormalities in patients taking lopinavir/ritonavir.
AIDS patient care and STDs 2003;17(9):443-5.
2003: García-Benayas Teresa; Blanco Francisco; Martín-Carbonero Luz; Valencia Eulalia; Barrios Ana; González-Lahoz Juan; Soriano Vincent
Gynecomastia in HIV-infected patients receiving antiretroviral therapy.
AIDS research and human retroviruses 2003;19(9):739-41.
2003: Barrios Ana; de Mendoza Carmen; Martín-Carbonero Luz; Ribera Esteve; Domingo Pere; Galindo María José; Gálvez Juan; Estrada Vicente; Dalmau David; Asensi Víctor; Soriano Vincent
Role of baseline human immunodeficiency virus genotype as a predictor of viral response to tenofovir in heavily pretreated patients.
Journal of clinical microbiology 2003;41(9):4421-3.
2003: Pérez-Olmeda Mayte; Núñez Marina; García-Samaniego Javier; Ríos Pilar; González-Lahoz Juan; Soriano Vincent
Distribution of hepatitis B virus genotypes in HIV-infected patients with chronic hepatitis B: therapeutic implications.
AIDS research and human retroviruses 2003;19(8):657-9.
2003: Poveda Eva; de Mendoza Carmen; Cuesta Marta; Toro Carlos; Rodés Berta; Soriano Vincent
Can drug resistance mutations influence the measurement of plasma HIV-RNA by different viral load techniques?
AIDS patient care and STDs 2003;17(7):321-4.
2003: Barreiro Pablo; Camino Nuria; De Julián Rosa; González-Lahoz Juan; Soriano Vincent
Replacement of protease inhibitors by nevirapine or efavirenz in simplification and rescue interventions: which works better?
HIV clinical trials 2003;4(4):244-7.
2003: González de Requena Daniel; Gallego Oscar; de Mendoza Carmen; Corral Angélica; Jiménez-Nácher Inmaculada; Soriano Vincent
Indinavir plasma concentrations and resistance mutations in patients experiencing early virological failure.
AIDS research and human retroviruses 2003;19(6):457-9.
2003: Toro Carlos; Rodés Berta; Colino Félix; del Valle Flores Maria; Poveda Eva; de Mendoza Carmen; Téllez Maria Jesús; Soriano Vincent
Transmission of HIV type 1 through blood transfusion from an antibody-negative/p24 antigen-negative donor.
AIDS research and human retroviruses 2003;19(6):447-8.
2003: Gallego Oscar; Corral Angelica; De Mendoza Carmen; Gonzalez-Lahoz Juan; Soriano Vincent
High rate of resistance to antiretroviral drugs among HIV-infected prison inmates.
Medical science monitor : international medical journal of experimental and clinical research 2003;9(6):CR217-21.
2003: Holguín Africa; Alvarez Amparo; Pena María José; Artiles Fernando; Molina Lourdes; Soriano Vincent
HIV-positive immigrants in the Canary Islands, Spain: implications for public health in Europe.
HIV clinical trials 2003;4(3):184-92.
2003: Núñez Marina; Asencio Román; Valencia M Eulalia; Leal Manuel; González-Lahoz Juan; Soriano Vincent
Rate, causes, and clinical implications of presenting with low CD4+ cell counts in the era of highly active antiretroviral therapy.
AIDS research and human retroviruses 2003;19(5):363-8.
2003: Pérez-Olmeda Mayte; Núñez Marina; Romero Miriam; González Juan; Castro Angeles; Arribas José Ramón; Pedreira José; Barreiro Pablo; García-Samaniego Javier; Martín-Carbonero Luz; Jiménez-Nácher Inmaculada; Soriano Vincent
Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients.
AIDS (London, England) 2003;17(7):1023-8.
2003: Holguín A; Hertogs K; Soriano V
Performance of drug resistance assays in testing HIV-1 non-B subtypes.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2003;9(4):323-6.
2003: García-Benayas Teresa; Blanco Francisco; de la Cruz Juan José; Soriano Vincent; González-Lahoz Juan
Replacing stavudine by abacavir reduces lactate levels and may improve lipoatrophy.
AIDS (London, England) 2003;17(6):921-4.
2003: Gallego Oscar; de Mendoza Carmen; Corral Angélica; Soriano Vincent
Low rate of HIV-1 codon 215 revertants in antiretroviral-experienced patients.
AIDS (London, England) 2003;17(6):919-21.
2003: Soriano Vincent; Pérez-Olmeda Mayte; Ríos Pilar; Núñez Marina; García-Samaniego Javier; González-Lahoz Juan
Is treatment failure for hepatitis C virus infection in HIV-positive drug users associated with a shift in HCV genotypes?
Journal of acquired immune deficiency syndromes (1999) 2003;32(4):465-6.
2003: Camino Nuria; Núñez Marina; Blanco Francisco; González-Requena Daniel; González-Lahoz Juan; Soriano Vincent
Indinavir-induced thrombocytopenia.
AIDS patient care and STDs 2003;17(3):103-4.
2003: Núñez Marina; González-Requena Daniel; González-Lahoz Juan; Soriano Vincent
Short communication: interactions between nevirapine plasma levels, chronic hepatitis C, and the development of liver toxicity in HIV-infected patients.
AIDS research and human retroviruses 2003;19(3):187-8.
2003: Martín-Carbonero Luz; Núñez Marina; González-Lahoz Juan; Soriano Vincent
Incidence of liver injury after beginning antiretroviral therapy with efavirenz or nevirapine.
HIV clinical trials 2003;4(2):115-20.
2003: Gallego Oscar; de Mendoza Carmen; Corral Angélica; Soriano Vincent
Changes in the human immunodeficiency virus p7-p1-p6 gag gene in drug-naive and pretreated patients.
Journal of clinical microbiology 2003;41(3):1245-7.
2003: Gonzàlez de Requena Daniel; Núñez Marina; de Mendoza Carmen; Jiménez-Nàcher Inmaculada; Soriano Vincent
Nelfinavir plasma concentrations in patients experiencing early failure with nelfinavir-containing triple combinations.
AIDS (London, England) 2003;17(3):442-4.
2003: Blanco Francisco; García-Benayas Teresa; José de la Cruz Juan; González-Lahoz Juan; Soriano Vincent
First-line therapy and mitochondrial damage: different nucleosides, different findings.
HIV clinical trials 2003;4(1):11-9.
2003: Toro Carlos; Rodés Berta; Poveda Eva; Soriano Vincent
Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor.
Transplantation 2003;75(1):102-4.
2002: Benito José M; López Mariola; Martín Juan C; Lozano Sara; Martínez Pilar; González-Lahoz Juan; Soriano Vincent
Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
AIDS research and human retroviruses 2002;18(18):1379-88.
2002: Barreiro Pablo; Camino Nuria; de Mendoza Carmen; Valer Luisa; Núñez Marina; Martín-Carbonero Luz; González-Lahoz Juan; Soriano Vincent
Comparison of the efficacy, safety and predictive value of HIV genotyping using distinct ritonavir-boosted protease inhibitors.
International journal of antimicrobial agents 2002;20(6):438-43.
2002: de Requena Daniel González; Núñez Marina; Gallego Oscar; Jiménez-Nácher Inmaculada; González-Lahoz Juan; Soriano Vincent
Does an increase in nevirapine plasma levels cause complete virologic suppression in patients experiencing early virologic failure?
HIV clinical trials 2002;3(6):463-7.
2002: Núñez Marina; Pérez-Olmeda Mayte; Díaz Beatriz; Ríos Pilar; González-Lahoz Juan; Soriano Vincent
Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine.
AIDS (London, England) 2002;16(17):2352-4.
2002: Rodés Berta; Poveda Eva; Soriano Vincent
Rapid assessment of phenotypic resistance to protease inhibitors in human immunodeficiency virus type 1 group O.
Journal of clinical microbiology 2002;40(11):4313-6.
2002: Barreiro Pablo; García-Benayas Teresa; Soriano Vincent; Gallant Joel
Simplification of antiretroviral treatment--how to sustain success, reduce toxicity and ensure adherence avoiding PI use.
AIDS reviews 2002;4(4):233-41.
2002: Garcia-Benayas Teresa; Blanco Francisco; Soriano Vincent
Weight loss in HIV-infected patients.
The New England journal of medicine 2002;347(16):1287-8.
2002: Núñez Marina; Ríos Pilar; Pérez-Olmeda Mayte; Soriano Vincent
Lack of 'occult' hepatitis B virus infection in HIV-infected patients.
AIDS (London, England) 2002;16(15):2099-101.
2002: Barrios Ana; Blanco Francisco; García-Benayas Teresa; Gómez-Viera José Manuel; de la Cruz Juan José; Soriano Vincent; González-Lahoz Juan
Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia.
AIDS (London, England) 2002;16(15):2079-81.
2002: Gallego Oscar; Ruíz Lidia; Vallejo Alex; Clotet Bonaventura; Leal Manuel; Soriano Vincent
Rate of virological treatment failure and frequencies of drug resistance genotypes among human immunodeficiency virus-positive subjects on antiretroviral therapy in Spain.
Journal of clinical microbiology 2002;40(10):3865-6.
2002: Holguín Africa; Soriano Vincent
Resistance to antiretroviral agents in individuals with HIV-1 non-B subtypes.
HIV clinical trials 2002;3(5):403-11.
2002: Toro Carlos; Soriano Vincent; Tuset Concepción; Aguilera Antonio; Caballero Estrella; de Lejarazu Raul Ortiz; Rodés Berta;
Infection with retroviruses other than HIV-1 in Spain: a retrospective analysis for HIV-2, HTLV-I, and/or HTLV-II.
HIV clinical trials 2002;3(5):397-402.
2002: Valer Luisa; De Mendoza Carmen; De Requena Daniel González; Labarga Pablo; García-Henarejos Adolfo; Barreiro Pablo; Guerrero Francisca; Vergara Antonio; Soriano Vincent;
Impact of HIV genotyping and drug levels on the response to salvage therapy with saquinavir/ritonavir.
AIDS (London, England) 2002;16(14):1964-6.
2002: Poveda Eva; Rodés Berta; Toro Carlos; Martín-Carbonero Luz; Gonzalez-Lahoz Juan; Soriano Vincent
Evolution of the gp41 env region in HIV-infected patients receiving T-20, a fusion inhibitor.
AIDS (London, England) 2002;16(14):1959-61.
2002: Núnez Marina; de Mendoza Carmen; Valer Luisa; Casas Esperanza; López-Calvo Soledad; Castro Angeles; Rosón Beatriz; Podzamczer Daniel; Rubio Amalia; Berenguer Juan; Soriano Vincent
Resistance mutations in HIV-infected patients experiencing early failure with nelfinavir-containing triple combinations.
Medical science monitor : international medical journal of experimental and clinical research 2002;8(9):CR620-3.
2002: de Mendoza Carmen; del Romero Jorge; Rodríguez Carmen; Corral Angélica; Soriano Vincent
Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid.
AIDS (London, England) 2002;16(13):1830-2.
2002: Gallego Oscar; Corral Angélica; de Mendoza Carmen; Rodés Berta; Soriano Vincent
Prevalence of G333D/E in naive and pretreated HIV-infected patients.
AIDS research and human retroviruses 2002;18(12):857-60.
2002: de Mendoza Carmen; Martín-Carbonero Luz; Barreiro Pablo; Diaz Beatriz; Valencia Eulalia; Jiménez-Nácher Inmaculada; Gallego Oscar; Núñez Marina; González-Lahoz Juan; Soriano Vincent
Salvage treatment with lopinavir/ritonavir (Kaletra) in HIV-infected patients failing all current antiretroviral drug families.
HIV clinical trials 2002;3(4):304-9.
2002: Toro Carlos; Rodés Berta; Aguilera Antonio; Caballero Estrella; Benito Rafael; Tuset Concepción; García Juan; De Lejarazu Raúl Ortiz; Eirós José M; Calderón Enrique; Rodriguez Carmen; Soriano Vincent;
Clinical impact of HTLV-1 infection in Spain: implications for public health and mandatory screening.
Journal of acquired immune deficiency syndromes (1999) 2002;30(3):366-8.
2002: Martín-Carbonero Luz; Núñez Marina; Ríos Pilar; Pérez-Olmeda Mayte; González-Lahoz Juan; Soriano Vincent
Liver injury after beginning antiretroviral therapy in HIV/hepatitis C virus co-infected patients is not related to immune reconstitution.
AIDS (London, England) 2002;16(10):1423-5.
2002: Núñez Marina; Ríos Pilar; Martín-Carbonero Luz; Pérez-Olmeda Mayte; González-Lahoz Juan; Soriano Vincent
Role of hepatitis C virus genotype in the development of severe transaminase elevation after the introduction of antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2002;30(1):65-8.
2002: Soriano Vincent; de Mendoza Carmen
Genetic mechanisms of resistance to protease inhibitors and entry inhibitors.
HIV clinical trials 2002;3(3):249-57.
2002: Soriano Vincent; de Mendoza Carmen
Genetic mechanisms of resistance to NRTI and NNRTI.
HIV clinical trials 2002;3(3):237-48.
2002: Núñez Marina; Soriano Vincent; Martín-Carbonero Luz; Barrios Ana; Barreiro Pablo; Blanco Francisco; García-Benayas Teresa; González-Lahoz Juan
SENC (Spanish efavirenz vs. nevirapine comparison) trial: a randomized, open-label study in HIV-infected naive individuals.
HIV clinical trials 2002;3(3):186-94.
2002: Holguín Africa; Alvarez Amparo; Soriano Vincent
HIV-1 subtype J recombinant viruses in Spain.
AIDS research and human retroviruses 2002;18(7):523-9.
2002: Holguín Africa; Alvarez Amparo; Soriano Vincent
High prevalence of HIV-1 subtype G and natural polymorphisms at the protease gene among HIV-infected immigrants in Madrid.
AIDS (London, England) 2002;16(8):1163-70.
2002: García-Benayas Teresa; Blanco Francisco; Gómez-Viera Jose Manuel; Barrios Ana; Soriano Vincent; González-Lahoz Juan
Lipodystrophy body-shape changes in a patient undergoing zidovudine monotherapy.
AIDS (London, England) 2002;16(7):1087-9.
2002: de Mendoza Carmen; Alcamí José; Sainz María; Folgueira Dolores; Soriano Vincent
Evaluation of the Abbott LCx quantitative assay for measurement of human immunodeficiency virus RNA in plasma.
Journal of clinical microbiology 2002;40(4):1518-21.
2002: Martín J C; Holguín A; Soriano V
Prevalence of different HIV-1 subtypes in an urban clinic in Madrid.
Sexually transmitted infections 2002;78(1):E1.
2002: Pérez-Olmeda Mayte; Ríos Pilar; Núñez Marina; García-Samaniego Javier; Romero Miriam; Soriano Vincent
Virological characteristics of hepatitis C virus infection in HIV-infected individuals with chronic hepatitis C: implications for treatment.
AIDS (London, England) 2002;16(3):493-5.
2002: de Mendoza Carmen; Ramos José Tomás; Ciria Luis; Fortuny Claudia; García Francisco José; de José María Isabel; Asensi Francisco; Soriano Vincent
Efficacy and safety of stavudine plus didanosine in asymptomatic HIV-infected children with plasma HIV RNA below 50,000 copies per milliliter.
HIV clinical trials 2002;3(1):9-16.
2002: González de Requena Daniel; Núñez Marina; Jiménez-Nácher Inmaculada; Soriano Vincent
Liver toxicity caused by nevirapine.
AIDS (London, England) 2002;16(2):290-1.
2002: Barreiro Pablo; Soriano Vincent; Casas Esperanza; González-Lahoz Juan
Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides.
AIDS (London, England) 2002;16(2):245-9.
2001: Martín J C; Soriano V; Jiménez-Nácher I; Martínez P; González-Lahoz J
Overall trends in CD4 counts and plasma viremia in an urban clinic since the introduction of highly active antiretroviral therapies.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2001;7(12):678-81.
2001: García-Benayas T; Blanco F; de la Cruz J J; Senchordi M J; Gómez-Viera J M; Soriano V; González-Lahoz J
Role of nonnucleosides in the development of HAART-related lipid disturbances.
Journal of acquired immune deficiency syndromes (1999) 2001;28(5):496-8.
2001: Núñez M; González de Requena D; Gallego L; Jiménez-Nácher I; González-Lahoz J; Soriano V
Higher efavirenz plasma levels correlate with development of insomnia.
Journal of acquired immune deficiency syndromes (1999) 2001;28(4):399-400.
2001: Martín-Carbonero L; Soriano V; Valencia E; García-Samaniego J; López M; González-Lahoz J
Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients.
AIDS research and human retroviruses 2001;17(16):1467-71.
2001: Machuca A; Rodés B; Soriano V
The effect of antiretroviral therapy on HTLV infection.
Virus research 2001;78(1-2):93-100.
2001: Gallego O; de Mendoza C; Pérez-Elías M J; Guardiola J M; Pedreira J; Dalmau D; Gónzalez J; Moreno A; Arribas J R; Rubio A; García-Arata I; Leal M; Domingo P; Soriano V
Drug resistance in patients experiencing early virological failure under a triple combination including indinavir.
AIDS (London, England) 2001;15(13):1701-6.
2001: Núñez M; Lana R; Mendoza J L; Martín-Carbonero L; Soriano V
Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2001;27(5):426-31.
2001: de Mendoza C; Lu W; Machuca A; Sainz M; Castilla J; Soriano V
Monitoring the response to antiretroviral therapy in HIV-1 group O infected patients using two new RT-PCR assays.
Journal of medical virology 2001;64(3):217-22.
2001: Holguín A; Aracil B; Alvarez A; Barros C; Soriano V
Prevalence of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5.
Journal of clinical microbiology 2001;39(5):1850-4.
2001: Soriano V; Barreiro P; de Mendoza C; Dona C; González-Lahoz J
Monthly cyclic therapy in heavily pretreated HIV-infected patients.
AIDS patient care and STDs 2001;15(4):177-9.
2001: Núñez M; Rodríguez-Rosado R; Soriano V
Intensification of antiretroviral therapy.
AIDS research and human retroviruses 2001;17(6):499-506.
2001: Briones C; Pérez-Olmeda M; Rodríguez C; del Romero J; Hertogs K; Soriano V
Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid.
Journal of acquired immune deficiency syndromes (1999) 2001;26(2):145-50.
2001: Pérez-Olmeda M; Del Romero J; Rubio A; Ruiz L; Rodríguez C; Leal M; Clotet B; Soriano V
Primary HIV-1 drug resistance in Spain before and after the introduction of protease inhibitors.
Journal of medical virology 2001;63(2):85-7.
2001: Briones C; Mas A; Pérez-Olmeda M; Altisent C; Domingo E; Soriano V
Prevalence and genetic heterogeneity of the reverse transcriptase T69S-S-X insertion in pretreated HIV-infected patients.
Intervirology 2001;44(6):339-43.
2000: Martín-Carbonero L; Barreiro P; Soriano V; González-Lahoz J
Tolerability of abacavir in the clinical setting.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2000;6(11):621-2.
2000: de Mendoza C; Soriano V; Pérez-Olmeda M; Rodríguez-Rosado R; González-Lahoz J
Efficacy and safety of didanosine and lamivudine both once daily plus indinavir in human immunodeficiency virus-infected patients.
Journal of human virology 2000;3(6):335-40.
2000: Machuca A; Tuset C; Soriano V; Caballero E; Aguilera A; Ortiz de Lejarazu R;
Prevalence of HTLV infection in pregnant women in Spain.
Sexually transmitted infections 2000;76(5):366-70.
2000: Soriano V; Rodríguez-Rosado R; Pérez-Olmeda M; Romero M; García-Samaniego J
Interferon plus ribavirin for chronic hepatitis C in HIV-infected patients.
AIDS (London, England) 2000;14(15):2409-10.
2000: Dona C; Soriano V; Barreiro P; Jiménez-Náchera I; González-Lahoz J
[Toxicity associated to efavirenz in HIV-infected persons enrolled in an expanded access program]
Medicina clínica 2000;115(9):337-8.
2000: Barreiro P; Soriano V; Casas E; Estrada V; Téllez M J; Hoetelmans R; de Requena D G; Jimenéz-Nácher I; González-Lahoz J
Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids.
AIDS (London, England) 2000;14(14):2153-7.
2000: Núñez M; Soriano V
Salvage therapy for HIV infection: when and how.
AIDS patient care and STDs 2000;14(9):465-76.
2000: Holguín A; Rodés B; Soriano V
Protease gene analysis of HIV type 1 non-B subtypes in Spain.
AIDS research and human retroviruses 2000;16(14):1395-403.
2000: Soriano V; Dona C; Barreiro P; González-Lahoz J
Is there cross-toxicity between nevirapine and efavirenz in subjects developing rash?
AIDS (London, England) 2000;14(11):1672-3.
2000: Briones C; Soriano V; González-Lahoz J
Prevalence of drug-resistant HIV-1 genotypes in heavily pre-treated patients on current virological failure.
AIDS (London, England) 2000;14(11):1659-60.
2000: Pieniazek D; Rayfield M; Hu D J; Nkengasong J; Wiktor S Z; Downing R; Biryahwaho B; Mastro T; Tanuri A; Soriano V; Lal R; Dondero T
Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide. HIV Variant Working Group.
AIDS (London, England) 2000;14(11):1489-95.
2000: Shanmugam V; Switzer W M; Nkengasong J N; García-Lerma G; Green T A; Ekpini E; Sassan-Morokro M; Antunes F; Manshino K; Soriano V; Wiktor S Z; Heneine W
Lower HIV-2 plasma viral loads may explain differences between the natural histories of HIV-1 and HIV-2 infections.
Journal of acquired immune deficiency syndromes (1999) 2000;24(3):257-63.
2000: Machuca A; Soriano V
In vivo fluctuation of HTLV-I and HTLV-II proviral load in patients receiving antiretroviral drugs.
Journal of acquired immune deficiency syndromes (1999) 2000;24(2):189-93.
2000: Briones C; Soriano V; Dona C; Barreiro P; González-Lahoz J
Can early failure with nevirapine be rescued with efavirenz?
Journal of acquired immune deficiency syndromes (1999) 2000;24(1):76-8.
2000: Núñez M; Machuca A; Soriano V; Podzamczer D; González-Lahoz J
Clearance of human herpesvirus type 8 viraemia in HIV-1-positive patients with Kaposi's sarcoma treated with liposomal doxorubicin. Caelyx/KS Spanish Study Group.
AIDS (London, England) 2000;14(8):913-9.
2000: Barreiro P; Soriano V; Blanco F; Casimiro C; de la Cruz J J; González-Lahoz J
Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy.
AIDS (London, England) 2000;14(7):807-12.
2000: Soriano V; Gomes P; Heneine W; Holguín A; Doruana M; Antunes R; Mansinho K; Switzer W M; Araujo C; Shanmugam V; Lourenço H; González-Lahoz J; Antunes F
Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load.
Journal of medical virology 2000;61(1):111-6.
2000: Rodés B; Holguín A; Soriano V; Dourana M; Mansinho K; Antunes F; González-Lahoz J
Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy.
Journal of clinical microbiology 2000;38(4):1370-4.
2000: Barreiro P; Soriano V; Cabello N; González-Lahoz J
Is there a role for indinavir twice-daily in clinical practice?
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2000;6(3):152-4.
2000: Holguín A; Rodés B; Soriano V
Recombinant human immunodeficiency viruses type 1 circulating in Spain.
AIDS research and human retroviruses 2000;16(5):505-11.
2000: Soriano V; Dona C; Rodríguez-Rosado R; Barreiro P; González-Lahoz J
Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy.
AIDS (London, England) 2000;14(4):383-6.
2000: Briones C; Mas A; Gómez-Mariano G; Altisent C; Menéndez-Arias L; Soriano V; Domingo E
Dynamics of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy.
Virus research 2000;66(1):13-26.
2000: García Lerma J G; Soriano V; Mas A; Quiñones-Mateu M E; Arts E J; Heneine W
Quantitation of human immunodeficiency virus type 1 group O load in plasma by measuring reverse transcriptase activity.
Journal of clinical microbiology 2000;38(1):402-5.
1999: de Mendoza C; Soriano V; Pérez-Olmeda M; Rodés B; Casas E; González-Lahoz J
Different outcomes in patients achieving complete or partial viral load suppression on antiretroviral therapy.
Journal of human virology 1999;2(6):344-9.
1999: Rodríguez-Rosado R; Soriano V; Barreiro P; Dona C; González-Lahoz J
What dual protease inhibitor combination for salvage therapies?
AIDS (London, England) 1999;13(15):2180-1.
1999: Holguín A; Rodés B; Dietrich U; Soriano V
Human immunodeficiency viruses type 1 subtypes circulating in Sspain.
Journal of medical virology 1999;59(2):189-93.
1999: Rodríguez-Rosado R; Soriano V; Blanco F; Dona C; González-Lahoz J
Diabetes mellitus associated with protease inhibitor use.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(9):675-7.
1999: de Mendoza C; Soriano V; González-Lahoz J
Association between submaximal suppression of HIV replication and use of drug combinations without protease inhibitors.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(8):604-5.
1999: Pérez-Olmeda M; Rodríguez-Rosado R; Gómez-Cano M; Briones C; Soriano V
Usefulness of genotypic analysis of resistance to nucleoside analogues in the clinical setting.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(6):448-9.
1999: Villalba N; Pérez-Olmeda M; de José M; Hernández M; Sirera R; Español T; González-Molina A; Soriano V
CCR5 genotype and human immunodeficiency virus type 1 infection in perinatally exposed infants.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(5):389-91.
1999: Villalba N; Gómez-Cano M; Holguín A; Soriano V
Multiple drug resistance genotype causing failure of antiretroviral treatment in an HIV-infected patient heavily exposed to nucleoside analogues.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(5):372-5.
1999: Holguín A; de Mendoza C; Soriano V
Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(4):256-9.
1999: García-Silva J; Almagro M; Peña C; López Calvo S; Castro A; Soriano V; Fonseca E
CD4+ T-lymphocytopenia, Kaposi's sarcoma, HHV-8 infection, severe seborrheic dermatitis, and onychomycosis in a homosexual man without HIV infection.
International journal of dermatology 1999;38(3):231-3.
1999: Vallejo A; Mas A; Heredia A; Altisent C; Lorenzo I; Soriano V; Hewlett I K
V3-loop and nef gene sequences of HIV-1 isolates from a hemophiliac cohort with long-term non-progressive infection.
AIDS (London, England) 1999;13(4):532-4.
1999: García Lerma J; Schinazi R F; Juodawlkis A S; Soriano V; Lin Y; Tatti K; Rimland D; Folks T M; Heneine W
A rapid non-culture-based assay for clinical monitoring of phenotypic resistance of human immunodeficiency virus type 1 to lamivudine (3TC).
Antimicrobial agents and chemotherapy 1999;43(2):264-70.
1999: Soriano V; Machuca A; Gutiérrez M
Human T-cell leukemia/lymphoma virus type II infection in Spain. HTLV Spanish Study Group.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(1):75-7.
1999: Soriano V; García-Samaniego J; Valencia E; Rodríguez-Rosado R; Muñoz F; González-Lahoz J
Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users.
European journal of epidemiology 1999;15(1):1-4.
1999: Mas A; Español T; Heredia A; Pedraza M A; Hernandez M; Caragol I; Fernando M; Bertran J M; Alcami J; Soriano V
CCR5 genotype and HIV-1 infection in perinatally-exposed infants.
The Journal of infection 1999;38(1):9-11.
1999: Soriano V
Prevalence of drug resistance mutations in Spain among both naive and pretreated patients.
Antiviral therapy 1999;4 Suppl 3():57-63.
1999: Pèrez-Olmeda M; Rubio A; Puig T; Gômez-Cano M; Ruiz L; Leal M; Clotet B; Soriano V
Evolution of genotypic resistance to nucleoside analogues in patients receiving protease inhibitor-containing regimens.
Antiviral therapy 1999;4(3):179-81.
1999: Briones C; Soriano V
Different outcome in the first two patients with an HIV-1 multinucleoside drug-resistant T69SSS insertion in Spain.
Antiviral therapy 1999;4(2):125-7.
1999: Gómez-Cano M; Rubio A; Ruiz L; Pérez-Olmeda M; Leal M; Clotet B; Soriano V
Efficiency of drug resistance genotypic tests in specimens with low HIV viral load.
Antiviral therapy 1999;4(2):123-4.
1999: Soriano V; Garcìa-Samaniego J; Rodrìguez-Rosado R; Gonzàlez J; Pedreira J
Hepatitis C and HIV infection: biological, clinical, and therapeutic implications.
Journal of hepatology 1999;31 Suppl 1():119-23.
1999: Machuca A; Soriano V; Guti rrez M; Holguín A; Aguilera A; Caballero E; Cilla G
Human immunodeficiency virus type 2 infection in Spain. The HIV-2 Spanish Study Group.
Intervirology 1999;42(1):37-42.
1998: Machuca A; Gutiérrez M; Holguín A; Camba M; Belda J; Soriano V
[7 new cases of HIV-2 infection recognized in Madrid in 1996 and 1997]
Revista clínica española 1998;198(10):660-4.
1998: de Mendoza C; Holguín A; Soriano V
False positives for HIV using commercial viral load quantification assays.
AIDS (London, England) 1998;12(15):2076-7.
1998: Vallejo A; Heredia A; Mas A; Lee S F; Epstein J S; Soriano V; Hewlett I K
Tropism, coreceptor use, and phylogenetic analysis of both the V3 loop and the protease gene of three novel HIV-1 group O isolates.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;18(5):417-25.
1998: Soriano V; Castilla J; Gómez-Cano M; Holguín A; Villalba N; Mas A; González-Lahoz J
The decline in CD4+ T lymphocytes as a function of the duration of HIV infection, age at seroconversion, and viral load.
The Journal of infection 1998;36(3):307-11.
1998: Gómez-Cano M; Soriano V; Pérez-Olmeda M; Machuca A; Rodríguez-Rosado R; Valencia E; Moreno V; Gutiérrez M; González-Lahoz J
Long-term suppression of HIV replication in patients with sustained benefit on zidovudine monotherapy.
AIDS (London, England) 1998;12(8):964-6.
1998: García Lerma J G; Yamamoto S; Gómez-Cano M; Soriano V; Green T A; Busch M P; Folks T M; Heneine W
Measurement of human immunodeficiency virus type 1 plasma virus load based on reverse transcriptase (RT) activity: evidence of variabilities in levels of virion-associated RT.
The Journal of infectious diseases 1998;177(5):1221-9.
1998: Soriano V; Gómez-Cano M; Castilla J; Villalba N; Holguín A; Bravo R; Mas A; Pérez-Labad M L; González-Lahoz J
[Interrelationship between the duration of HIV infection, viral load and CD4 positive lymphocyte count]
Medicina clínica 1998;110(14):529-31.
1998: Heredia A; Vallejo A; Soriano V; Silva A; Mansinho K; Fevereiro S; Mas A; Gutierrez M; Epstein J S; Hewlett I K
Phylogenetic analysis of HIV type 2 strains from Portugal.
AIDS research and human retroviruses 1998;14(6):471-3.
1998: Casas E; Gómez-Cano M; Adrados M; García-Lerma G; Calvo F; Soriano V
[Combined antiretroviral therapy for prevention of vertical HIV-1 transmission]
Anales de medicina interna (Madrid, Spain : 1984) 1998;15(3):148-51.
1998: Gómez-Cano M; Soriano V; García-Lerma G; González-Lahoz J
[Efficacy of combining zidovudine plus didanosine in patients with and without previous exposure to zidovudine]
Anales de medicina interna (Madrid, Spain : 1984) 1998;15(3):145-7.
1998: Gómez-Cano M; Soriano V; Polo R; Valencia E; Adrados M; González-Lahoz J
[Efficacy of ritonavir in HIV positive patients pretreated with nucleoside analogues]
Anales de medicina interna (Madrid, Spain : 1984) 1998;15(2):83-6.
1998: Heredia A; Vallejo A; Soriano V; Aguilera A; Caballero E; Epstein J S; Hewlett I K
Genetic analysis of human immunodeficiency virus type 2 strains from Spain.
AIDS research and human retroviruses 1998;14(1):91-4.
1998: Janini L M; Tanuri A; Schechter M; Peralta J M; Vicente A C; Dela Torre N; Pieniazek N J; Luo C C; Ramos A; Soriano V; Schochetman G; Rayfield M A; Pieniazek D
Horizontal and vertical transmission of human immunodeficiency virus type 1 dual infections caused by viruses of subtypes B and C.
The Journal of infectious diseases 1998;177(1):227-31.
1998: Switzer W M; Wiktor S; Soriano V; Silva-Graça A; Mansinho K; Coulibaly I M; Ekpini E; Greenberg A E; Folks T M; Heneine W
Evidence of Nef truncation in human immunodeficiency virus type 2 infection.
The Journal of infectious diseases 1998;177(1):65-71.
1998: Rodríguez-Rosado R; Soriano V; Dona C; González-Lahoz J
Opportunistic infections shortly after beginning highly active antiretroviral therapy.
Antiviral therapy 1998;3(4):229-31.
1998: Machuca A; Gutiérrez M; Mur A; Soriano V
Quantitative p24 antigenaemia for monitoring response to antiretroviral therapy in HIV-1 group O-infected patients.
Antiviral therapy 1998;3(3):187-9.
1998: Holguín A; Dietrich U; Immelmann A; Soriano V
Genotypic and phenotypic resistance to stavudine after long-term monotherapy. BMS-020 Spanish Study Group.
Antiviral therapy 1998;3(3):183-6.
1997: Holguín A; Williams L; Castilla J; Soriano V
Influence of time and storage conditions on plasma HIV viral load measurements.
Antiviral therapy 1997;2(4):265-8.
1997: Laguna F; Adrados M; Alvar J; Soriano V; Valencia M E; Moreno V; Polo R; Verdejo J; Jiménez M I; Martínez P; Martínez M L; González-Lahoz J M
Visceral leishmaniasis in patients infected with the human immunodeficiency virus.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1997;16(12):898-903.
1997: Soriano V; Gómez-Cano M; Mas A; Villalba N; Castilla J; Adrados M; Laguna F; Polo R; González-Lahoz J
[Quantification of viremia in patients infected with human immunodeficiency virus with different degrees of immunosuppression]
Revista clínica española 1997;197(12):810-3.
1997: Villalba N; Gómez-Cano M; Casas E; Soriano V; Valencia E; González-Lahoz J
Safety and efficacy of two different triple drug combinations in which either lamivudine or didanosine were administered with stavudine plus indinavir.
AIDS (London, England) 1997;11(15):1896-7.
1997: Soriano V; Bravo R; García-Samaniego J; Ortega E; González J; Colmenero M; Castilla J; Castro A; Suárez D
A pilot study on the efficacy of escalating dosage of alpha-interferon for chronic hepatitis C in HIV-infected patients. The Hepatitis/HIV Spanish Study Group.
The Journal of infection 1997;35(3):225-30.
1997: Soriano V; Bravo R; García-Samaniego J; Castilla J; Castro A; Carballo E; González-Anglada I; Moreno A
Co-infection with several HCV genotypes enhances liver damage in patients with chronic hepatitis C. The Hepatitis/HIV Spanish Study Group.
The Journal of infection 1997;35(2):202-3.
1997: Eulalia Valencia M; Enríquez A; Soriano V; Moreno V; Laguna F; González Lahoz J
[Nosocomial infection with methicillin resistant Staphylococcus aureus in 14 human immunodeficiency virus infected patients]
Medicina clínica 1997;109(7):261-3.
1997: Gómez-Cano M; Villalba N; Mas A; Holguín A; Soriano V
[Antiretroviral treatment and resistance]
Revista clínica española 1997;197(8):574-82.
1997: Villalba N; Soriano V; Gómez-Cano M; Castilla J; Mas A; González-Lahoz J
Short-term efficacy and safety of stavudine in pretreated HIV-infected patients.
Antiviral therapy 1997;2(3):185-9.
1997: Heredia A; Vallejo A; Soriano V; Epstein J S; Hewlett I K
Chemokine receptors and HIV-2.
AIDS (London, England) 1997;11(9):1198-9.
1997: Heredia A; Vallejo A; Soriano V; Aguilera A; Mas A; Epstein J S; Hewlett I K
Genetic analysis of an HIV type 2 subtype B virus from a Spanish individual with AIDS.
AIDS research and human retroviruses 1997;13(10):899-900.
1997: Soriano V; Heredia A; Mas A; Vallejo A; Garcia-Lerma G; Bravo R; Gómez-Cano M; Villalba N; Moreno V; Laguna F; Valencia E; Martínez P; González-Lahoz J
[Frequency and characteristics of patients treated with zidovudine and absence of progression of HIV infection]
Anales de medicina interna (Madrid, Spain : 1984) 1997;14(6):282-5.
1997: Soriano V; Gömez-Cano M; Bravo R; Mas A; Villalba N; Holguín A; González-Lahoz J; Castilla J
Comparison of three different commercial methods for quantification of plasma HIV RNA in clinical specimens.
Antiviral therapy 1997;2(2):119-20.
1997: Soriano V; Dietrich U; Villalba N; Immelmann A; Gil-Aguado A; Echevarría S; Clotet B; Ocaña I; Santamaría J M; Bouza E; Barona V; Gatell J M; González-Lahoz J
Lack of emergence of genotypic resistance to stavudine after 2 years of monotherapy.
AIDS (London, England) 1997;11(5):696-7.
1997: Mas A; Soriano V; Gutiérrez M; Fumanal F; Alonso A; González-Lahoz J
Reliability of a new recombinant immunoblot assay (RIBA HIV-1/HIV-2 SIA) as a supplemental (confirmatory) test for HIV-1 and HIV-2 infections.
Transfusion science 1997;18(1):63-9.
1997: Soriano V; Bravo R; García-Samaniego J; Castilla J; González J; Castro A; Llibre J M
Relapses of chronic hepatitis C in HIV-infected patients who responded to interferon therapy. Hepatitis/HIV Spanish Study Group.
AIDS (London, England) 1997;11(3):400-1.
1997: Soriano V; Gómez-Cano M; Adrados M; Castilla J; Villalba N; Laguna F; González-Lahoz J
Short-term response to indinavir in patients with advanced HIV disease with prior heavy exposure to nucleoside analogues.
AIDS (London, England) 1997;11(3):391-2.
1997: Soriano V; Martínez-Zapico R; Gutiérrez M; Guerra A; Dronda F
Rising incidence of human T-cell leukaemia/lymphoma virus type II in Spanish drug users.
AIDS (London, England) 1997;11(4):549-50.
1997: Heredia A; Vallejo A; Soriano V; Gutierrez M; Puente S; Epstein J S; Hewlett I K
Evidence of HIV-2 infection in Equatorial Guinea (central Africa): partial genetic analysis of a B subtype virus.
AIDS research and human retroviruses 1997;13(5):439-40.
1997: Soriano V; Dietrich U; Mas A; Andersen R; Bravo R; Ruppach H; Gutiérrez M; Martínez-Zapico R; Rübsamen-Waigmann H; González-Lahoz J
[Serotypes of the human immunodeficiency virus type 1 in Madrid]
Medicina clínica 1997;108(6):217-20.
1996: Soriano V; Gómez-Cano M; Mas A; Villalba N; Bravo R; González-Lahoz J
Rationale for early antiretroviral therapy in patients with CD4 cell counts > 500 cells/mm3.
Antiviral therapy 1996;1(4):264-5.
1996: Soriano V; Mas A; Gómez-Cano M; Villalba N; Bravo R; González-Lahoz J
[Viral load and monitoring of antiretroviral treatment]
Revista clínica española 1996;196(12):872-7.
1996: Soriano V; Martín R; del Romero J; Castilla J; Bru F; Bravo R; Gutiérrez M; Martínez P; Valencia E; García S; Mas A; Moreno V; Laguna F; Rodríguez C; Sabín M L; González-Lahoz J
[Rapid and slow progression of the infection by the type 1 human immunodeficiency virus in a population of seropositive subjects in Madrid]
Medicina clínica 1996;107(20):761-6.
1996: Soriano V; Vallejo A; Gutiérrez M; Tuset C; Cilla G; Martínez-Zapico R; Dronda F; Caballero E; Calderón E; Aguilera A; Martín A M; Llibre J; del Romero J; Ortiz de Lejarazu R; Ulloa F; Eirós J; González-Lahoz J
Epidemiology of human T-lymphotropic virus type II (HTLV-II) infection in Spain. HTLV Spanish Study Group.
European journal of epidemiology 1996;12(6):625-9.
1996: Mas A; Quiñones-Mateu E; Soriano V; Domingo E
Env gene characterization of the first HIV type 1 group O Spanish isolate.
AIDS research and human retroviruses 1996;12(17):1647-9.
1996: García-Lerma G; Gutiérrez M; Mas A; Bravo R; Aguilera O; Soriano V
[Report of the first 2 cases of HIV-1 group O infection in Spain]
Medicina clínica 1996;107(11):418-21.
1996: Bravo R; Soriano V; García-Samaniego J; González J; Castro A; Colmenero M; Carballo E; Mas A; González-Lahoz J
[Prevalence of the genotypes of the hepatitis C virus in Spanish drug addicts with chronic hepatitis C. Spanish Group for the Study of Viral Hepatitis in HIV Positive Patients]
Revista clínica española 1996;196(10):673-7.
1996: Soriano V; Castilla J; González-Lahoz J; Martín R; Bru F; Del Romero J
High alcohol intake and slow progression to AIDS.
Genitourinary medicine 1996;72(5):382.
1996: Soriano V; Gutiérrez M; Merino F; Dronda F; Esparza B; Tuset C
Recent spread of human T lymphotropic virus type II among injecting drug users in Spain. HTLV Spanish Study Group.
The Journal of infectious diseases 1996;174(4):891-3.
1996: García-Lerma G; Soriano V; Gómez-Cano M; Bravo R; Mas A; del Romero J; Martín R; González-Lahoz J
Prevalence of zidovudine-resistant HIV-1 among rapid progressors.
AIDS (London, England) 1996;10(11):1292-3.
1996: Soriano V; García-Samaniego J; Bravo R; González J; Castro A; Castilla J; Martínez-Odriozola P; Colmenero M; Carballo E; Suárez D; Rodríguez-Piñero F J; Moreno A; del Romero J; Pedreira J; González-Lahoz J
Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(3):585-91.
1996: Soriano V; Mas A; Bravo R; Moreno V; González-Lahoz J
[Long term survival in an HIV-immunosuppressed patient treated with foscarnet]
Anales de medicina interna (Madrid, Spain : 1984) 1996;13(8):387-9.
1996: Valencia M E; Moreno V; Soriano V; Polo R; Verdejo J; Laguna F; González Lahoz J
[Colony-stimulating factors and HIV-related neoplasms]
Anales de medicina interna (Madrid, Spain : 1984) 1996;13(7):317-21.
1996: Soriano V; García-Samaniego J; Castilla J; Bravo R; Hermida M; González J; Colmenero M; Castro A; Carballo E
[Proposal of a rule for deciding the therapeutic option in chronic hepatitis C in HIV-infected patients. Spanish Group for the Study of Viral Hepatitis in HIV-infected Patients]
Revista clínica española 1996;196(7):488-91.
1996: Soriano V; García-Samaniego J
[Management of viral hepatitis in patients with HIV infection]
Revista clínica española 1996;196(7):479-87.
1996: Soriano V; Gutiérrez M; Caballero E; Cilla G; Fernández J L; Aguilera A; Tuset C; Dronda F; Martín A M; Carballo E; López I; González-Lahoz J
Epidemiology of HIV-2 infection in Spain. The HIV-2 Spanish Study Group.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1996;15(5):383-8.
1996: Soriano V; Gutierrez M; Vallejo A; Aguilera A; Pujol E; Calderon E; Gonzalez-Lahoz J
Epidemiology of HTLV-I infection in Spain. HTLV Spanish Study Group.
International journal of epidemiology 1996;25(2):443-9.
1996: Soriano V; García-Samaniego J; Bravo R; González J; Castro A; Martnez-Odriozola P; Colmenero M; Carballo E; Suárez D; Castilla J; Rodriguez-Piñero F J; Moreno A; del Romero J; Pedreira J; González-Lahoz J
[The treatment of chronic hepatitis C with interferon in patients infected with the human immunodeficiency virus. The Spanish Group for the Study of Viral Hepatitis in HIV+ Patients]
Medicina clínica 1996;106(13):486-90.
1996: Bravo R; Soriano V; García-Samaniego J; González J; Castro A; Colmenero M; Carballo E; Mas A; González-Lahoz J
Hepatitis C virus genotypes in different risk populations in Spain. The Hepatitis-HIV Spanish Study Group.
The Journal of infectious diseases 1996;173(2):509-12.
1996: Aguilera O; Gutiérrez M; Mas A; González-Castelao G; Soriano V
[HTLV-I infection in Spanish drug addicts]
Revista clínica española 1996;196(1):59-60.
1996: Soriano V; Andersen R; Mas A; Ruppach H; Bravo R; Gutiérrez M; Martinez-Zapico R; Rübsamen-Waigmann H; Dietrich U
Circulating HIV-1 serotypes in Spain.
Vox sanguinis 1996;70(4):236-7.
1996: Soriano V; Gutiérrez M; Heredia A; Bravo R; Aguilera O; Mas A; Hewlett I; Baquero M; González-Lahoz J
Serial dilutions on synthetic peptide-based assays can resolve dual seroreactivity to HIV-1 and HIV-2.
Vox sanguinis 1996;71(1):67-8.
1996: Soriano V; Gutiérrez M; García-Lerma G; Aguilera O; Mas A; Bravo R; Pérez-Labad M L; Baquero M; González-Lahoz J
First case of HIV-1 group O infection in Spain.
Vox sanguinis 1996;71(1):66.
1996: Soriano V; Bravo R; García-Samaniego J; Castro A; Carballo E; González-Anglada I; Martínez-Odriozola P; Colmenero M; Pedreira J
Circulating hepatitis C virus genotypes in Spain. The Hepatitis/HIV Spanish Study Group.
Vox sanguinis 1996;70(3):180-1.
1995: Soriano V; Mas A
[The actual risk of retrovirus transmission from transfusions]
Sangre 1995;40(5):407-16.
1995: Soriano V; Martín R; del Romero J
[The rapid and slow progression of HIV infection]
Revista clínica española 1995;195(10):708-14.
1995: Soriano V; Leal M
[Strategies for the prevention of human immunodeficiency virus infection]
Revista clínica española 1995;195(10):701-7.
1995: De Pouplana M; Soriano V; García-Samaniego J; Enríquez A; Muñoz F; González-Lahoz J
[Characteristics of chronic delta hepatitis in patients wih HIV infection]
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1995;87(10):721-4.
1995: Soriano V; Gutiérrez M; Vallejo A; Tuset C; Dronda F; Pujol E
[HTLV-II infection in Spain. Analysis of 113 cases identified until November, 1994. Spanish Group for the Study of HTLV/I/II]
Medicina clínica 1995;105(7):251-4.
1995: Soriano V; Gutiérrez M; Vallejo A; Aguilera A; Calderón E; Franco E
[HTLV-I infection in Spain. Analysis of 24 cases identified until November, 1994. Spanish Group for the Study of HTLV-I/II)]
Medicina clínica 1995;105(7):246-50.
1995: Soriano V; Gutiérrez M; Caballero E; Aguilera A; Cilla G; López I
[Type 2 human immunodeficiency virus infection (HIV-2) in Spain: analysis of the first 50 cases. Spanish Group for the Study of HIV-2]
Medicina clínica 1995;105(7):241-5.
1995: Soriano V; García-Samaniego J; Bravo R; Castro A; Odriozola P M; González J; Colmenero M; Carballo E; Suárez D; Llibre J M
Efficacy and safety of alpha-interferon treatment for chronic hepatitis C in HIV-infected patients. HIV-Hepatitis Spanish Study Group.
The Journal of infection 1995;31(1):9-13.
1995: Henrard D R; Soriano V; Robertson E; Gutierrez M; Stephens J; Dronda F; Miles F; Pujol E; Buytendorp M; Castro A
Prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infection among Spanish drug users measured by HTLV-1 assay and HTLV-1 and -2 assay. HTLV-1 and HTLV-2 Spanish Study Group.
Journal of clinical microbiology 1995;33(7):1735-8.
1995: Soriano V; Heredia A
[Residual risk of retrovirus transmission by transfusions]
Revista clínica española 1995;195(6):418-24.
1995: Soriano V; Heredia A; Bravo R; Gutiérrez M; González-Lahoz J
[Rapid progression to AIDS in a patient with infection from a strain of syncytium forming HIV-1]
Medicina clínica 1995;105(3):99-100.
1995: Soriano V; García-Samaniego J; Bravo R; Valencia E; Laguna F; de Pouplana M; Iñíguez A; Muñoz F; González-Lahoz J
[Morbidity and mortality associated with chronic viral hepatopathy in patients infected with the human immunodeficiency virus]
Medicina clínica 1995;104(17):641-4.
1995: Bravo R; Soriano V; Martín R; del Romero J; Dronda F; Gutiérrez M; Martínez P; Valencia E; Moreno V; Laguna F
[The quantification of human immunodeficiency virus viremia in patients with rapid and slow progression of the disease]
Medicina clínica 1995;104(14):530-4.
1995: de Pouplana M; Soriano V; Samaniego J G; Enríquez A; Muñoz F; González-Lahoz J
More severe course of delta hepatitis in HIV-infected patients [L]
Genitourinary medicine 1995;71(2):132-3.
1995: Vallejo A; Soriano V
[Human lymphotropic virus type I (HTLV-I)]
Medicina clínica 1995;104(11):426-35.
1995: Soriano V; Gutiérrez M; Tuset C; Martínez-Zapico R; Calderón E; González-Lahoz J
Avoiding false-negative results for HTLV-II using new serological assays.
The American journal of medicine 1995;98(1):103.
1995: Soriano V; Gutiérrez M; Vallejo A; Aguilera A; Calderón E; Escudero D
HTLV-I-associated illnesses in Spain. HTLV Spanish Study Group.
Vox sanguinis 1995;69(3):261-2.
1995: Soriano V; Gutiérrez M; Caballero E; Fernández J L; Carballo E; Aguilera A; Martín A M
HIV-2 in native Spanish individuals. HIV-2 Spanish Study Group.
Vox sanguinis 1995;68(2):137-8.
1994: Soriano V; Bravo R; Samaniego J G; González J; Odriozola P M; Arroyo E; Vicario J L; Castro A; Colmenero M; Carballo E
CD4+ T-lymphocytopenia in HIV-infected patients receiving interferon therapy for chronic hepatitis C. HIV-Hepatitis Spanish Study Group.
AIDS (London, England) 1994;8(11):1621-2.
1994: Soriano V; Valencia E; Laguna F; Gonzalez-Lahoz J
High morbidity and mortality associated with non-AIDS defining conditions in HIV-infected patients in Spain.
Genitourinary medicine 1994;70(5):355-6.
1994: Laguna F; García-Samaniego J; Soriano V; Valencia E; Redondo C; Alonso M J; González-Lahoz J M
Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: report of five cases and review.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;19(1):48-53.
1994: Soriano V; Gutiérrez M; Bravo R
[Serological diagnosis of HIV-1 infection]
Revista clínica española 1994;194(7):558-67.
1994: Soriano V; Gutiérrez M; Tuset C; Calderón E
[HTLV-I]
Revista clínica española 1994;194(7):551-7.
1994: Valencia M E; Guinea J; Soriano V; Martínez M L; Moreno V; Laguna F; Enríquez A; González Lahoz J
[Study of 164 episodes of infectious endocarditis in drug addicts: comparison of HIV positive and negative patients]
Revista clínica española 1994;194(7):535-9.
1994: Soriano V; Valencia E; Alba A; González-Lahoz J
[Xanthomonas maltophilia endocarditis in an AIDS patient]
Medicina clínica 1994;102(10):399.
1994: Soriano V; Gutiérrez M
[HIV-2]
Medicina clínica 1994;102(10):387-93.
1994: Gutiérrez M; Soriano V; Bravo R; Vallejo A; Gonzalez-Lahoz J
Seroreversion in patients with end-stage HIV infection.
Vox sanguinis 1994;67(2):238-9.
1993: Soriano V; Valencia E; Alba A; Laguna F; Moreno V; Alberdi J C; García-Samaniego J; González-Lahoz J
[Changes in the spectrum of the diseases in patients hospitalized with HIV infection]
Medicina clínica 1993;101(19):736-40.
1993: Soriano V; Calderon E; Gutierrez M; Tuset C; Martinez-Zapico R; Gonzalez-Lahoz J
Misdiagnosis of HTLV-II infection using HTLV-I screening assays. HTLV-I/II Spanish Study Group.
AIDS (London, England) 1993;7(10):1395.
1993: Valencia E; Soriano V; González-Lahoz J
[Treatment and prophylaxis of the principal infections associated with the human immunodeficiency virus]
Medicina clínica 1993;101(13):505-14.
1993: Soriano V; Gutiérrez M; González-Lahoz J
[Retrovirus: diagnostic tests and their interpretation (II). HIV-2, HTLV-I, and HTLV-II infection]
Medicina clínica 1993;101(7):264-8.
1993: Soriano V; Calderón E; Esparza B; Cilla G; Aguilera A; Gutiérrez M; Tor J; Pujol E; Merino F; Pérez-Trallero E
HTLV-I/II infections in Spain. The HTLV-I/II Spanish Study Group.
International journal of epidemiology 1993;22(4):716-9.
1993: Soriano V; Gutiérrez M; González-Lahoz J
[Retrovirus: diagnostic tests and their interpretation (I). Generalities and infection by HIV-1]
Medicina clínica 1993;101(6):219-26.
1993: Soriano V; Laguna F; Diaz F; Polo R; Moreno V; Cobo J; Gonzalez-Lahoz J
Pyomyositis in patients with HIV infection.
AIDS (London, England) 1993;7(7):1020-1.
1993: Soriano V; Moreno V; Alba A; Laguna F; González-Lahoz J
Kussmaul respiration and abdominal pain secondary to metabolic acidosis in AIDS patients with disseminated Mycobacterium avium complex infection receiving clofazimine.
AIDS (London, England) 1993;7(6):894-5.
1993: Soriano V; Concheiro Carro L; Gutiérrez M; Tuset C; Martínez-Zapico R; Ortiz de Lejarazu R; González A; Aguilera A; Codina G; Ulloa F
[Evaluation of various criteria for the interpretation of western blot for the diagnosis of human immunodeficiency virus infection. Spanish Group for the Study of HIV-2]
Medicina clínica 1993;100(15):561-6.
1993: Soriano V; Calderón E; Cilla G; Aguilera A; Merino F; Gutiérrez M
[Multicenter study of HTLV-I and HTLV-II infection in Spain. Spanish Group for the Study of HTLV-II/II Infection]
Medicina clínica 1993;100(13):492-6.
1993: Soriano V; Gutiérrez M; Tuset C; Martínez-Zapico R; Ortiz de Lejarazu R; Aguilera A; Codina G; González A; Ulloa F; Leal M
[A multicenter study of infection with human immunodeficiency virus type-2 (HIV-2) in Spain (1991). The Spanish Group for the Study of HIV-2]
Medicina clínica 1993;100(14):531-5.
1993: Soriano V; González-Lahoz J; León-Monzón M
[Retroviruses and autoimmune diseases]
Medicina clínica 1993;100(5):181-6.
1993: Soriano V; Gutiérrez M; Tuset C; Martínez-Zapico R; Ortiz de Lejarazu R; González A; Aguilera A; Codina G; Ulloa F; Leal M
Avoiding indeterminate results in HIV-1 western blot using synthetic peptide assays. HIV-2 Spanish Study Group.
Vox sanguinis 1993;64(4):250-1.
1993: Soriano V; Gutiérrez M; Esparza B; Cilla G; Pujol E; Aguilera A; Calderón E; Tor J; Cuende I; Merino F
HTLV-I and HTLV-II infections in Spain.
Vox sanguinis 1993;64(1):59-60.
1992: Soriano V; González-Lahoz J
[Clinical syndromes in HIV infection (part 2)]
Anales de medicina interna (Madrid, Spain : 1984) 1992;9(10):501-8.
1992: Soriano V; González-Lahoz J
[Clinical syndromes in HIV infection (1st of 2 parts)]
Anales de medicina interna (Madrid, Spain : 1984) 1992;9(9):455-62.
1992: Soriano V; Leal M; Fernández J L
[The seroepidemiology of infection with the human immunodeficiency virus type 2 (HIV-2) in Spain (1990). The Spanish Group for the Study and Follow-up of HIV-2 Infection]
Medicina clínica 1992;98(4):152-4.
1991: Soriano V; González Lahoz J
[Which HIV-infected individuals develop AIDS faster?]
Revista clínica española 1991;189(8):386-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Vincent Soriano

Research Profile (preview)

Disorders

Living Beings

Chemicals & Drugs

Geographic Areas

Concepts & Ideas

Physiology

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Vincent Soriano (preview)

All Publications